Your new experience awaits. Try the new design now and help us make it even better

REVIEW article

Front. Vet. Sci., 30 January 2026

Sec. Animal Nutrition and Metabolism

Volume 12 - 2025 | https://doi.org/10.3389/fvets.2025.1695160

This article is part of the Research TopicInnovative Solutions in Animal Nutrition to Enhance the Sustainability of the Zootechnical Production SystemView all 12 articles

Sustainable AGP alternatives: a systems approach to non-antibiotic growth regulators standardization, synergistic formulation and environmental safety

  • 1Inner Mongolia Saikexing Institute of Breeding and Reproductive Biotechnology in Domestic Animal, Hohhot, China
  • 2National Center of Technology Innovation for Dairy, Hohhot, China
  • 3Department of Animal Production, Riphah College of Veterinary Sciences, Riphah International University, Lahore, Pakistan
  • 4Key Laboratory of Animal Genetics, Breeding and Reproduction of Shaanxi Province, College of Animal Science and Technology, Northwest A&F University, Yangling, China
  • 5University Institute of Food Science and Technology, University of Lahore, Lahore, Pakistan
  • 6Faculty of Agriculture, University of Agriculture, Faisalabad, Pakistan
  • 7Research Center for Mongolian Genetic Resources of Plateau Animal and Teaching Center for Experimental Biology, School of Life Sciences, Inner Mongolia University, Hohhot, Inner Mongolia, China
  • 8State Key Laboratory of Reproductive Regulation and Breeding of Grassland Livestock, Inner Mongolia University, Hohhot, Inner Mongolia, China

Growing consumer preference for livestock products labeled “Raised without Antibiotics(RWA) or “No Antibiotics Ever(NAE), escalating crisis of antimicrobial resistance due to long use of antibiotic growth promoters (AGPs) along with stringent regulatory restrictions, has intensified the demand for sustainable alternatives. This review summarizes recent advances in non-antibiotic strategies to enhance livestock production while aligning with global regulatory bans on in-feed antibiotics. We first delineate the multifunctional mechanisms of AGPs, primarily through gut microbiota modulation and immunomodulation, to establish a benchmark for alternative efficacy. The core analysis critically evaluates leading antibiotic substitutes, including probiotics, prebiotics, synbiotics, organic acids, dietary enzymes, and phytogenic food additives (PFAs). Among all, PFAs rich in terpenoids and phenolics for their antimicrobial, antioxidant, and gut health promoting properties along with cost-efficiency, scalability, and one health implications are preferred alternative to antibiotics. Further, we underscore emerging technologies such as antimicrobial peptides (AMPs), hyper-immune egg yolk antibodies (IgY), bacteriophages, genomic medicines, and clays and trace minerals, highlighting commercially approved examples like bacteriophage to control Salmonella. Despite demonstrated success in improving feed efficiency, growth performance, and overall animal health, challenges regarding consistency, bioavailability, and regulatory approval persist. The conclusive evidence positions a strategic combination of these natural and advanced alternatives, particularly optimized PFA formulations, as a viable and sustainable pathway to achieving antibiotic-free animal husbandry, thereby mitigating AMR risks and ensuring future food security.

Graphical abstract
Diagram outlining a research process: Identifying genes related to mitochondrial metabolism using TCGA-CRC transcriptome profiling, visualized by a volcano plot and Venn diagram; data processed using R with training and validation sets; performance assessed by survival curves; constructing a nomogram for predicting immune therapy benefits and drug responses; evaluating core genes including TMEM68 with in vitro and in vivo validation; featuring pathways, clinical graphs, and molecular experiments.

Graphical Abstract.

Introduction

Antibiotics are extensively supplemented in animal feed to enhance livestock productivity by improving feed efficiency, preventing and controlling infections, and reducing mortality (1). However, their use poses significant drawbacks, including the potential to drive antimicrobial resistance and jeopardize human health (259). AMR represents a critical public health challenge due to the emergence, transmission, and persistence of multidrug resistance (MDR) pathogens across animal, human, and environmental ecosystem. AMR is responsible for ~ 700,000 human deaths annually, with projections suggesting their figure could escalate to 10 million per year by 2050 (2). Recognizing the gravity of this threat, the WHO issued guidelines in 1997 and EU prohibited use of antibiotics as growth promoters in 2006 (3). In US, increasing consumer awareness and demand for antibiotic-free animal products have intensified scrutiny of antibiotic use in livestock (4). In response, the US Food and Drug Administration (FDA) mandated in 2013 (Guidance for Industry #213) that major animal pharmaceutical companies cease labeling antibiotics for growth promotion and instead require veterinary oversight for therapeutic applications. This regulatory shift was further reinforced by the implementation of the Veterinary Feed Directive (VFD) in 2015 (5). Over the past two decades, research into alternative antimicrobials – particularly plant-derived antibiotic substitutes – has expanded significantly as a strategy to reduce reliance on antibiotics in animal husbandry. The WHO identifies >1,340 plants with antimicrobial properties, yielding >30,000 bioactive compounds (6, 7). These secondary metabolites—terpenoids, phenolics, and alkaloids—serve ecological roles (e.g., pest resistance) and offer potential as AGP alternatives. Extensive evaluation of AGPs prior to administration must extend beyond zootechnical parameters such as weight gain, and FCR to include their potential for AMR mitigation. This review proposes integration of natural and advanced antibiotic alternatives as potential growth promoters to constitute a viable and sustainable antibiotic-free animal husbandry.

Mechanism of action of antibiotic growth promoters

Understanding the mechanism of action of AGPs is essential for identifying effective antibiotic alternatives. AGPs reduce gut microbiota diversity and abundance, diminishing competition for nutrients and suppressing microbial metabolites that impair growth, such as those involved in bile and amino acid catabolism (8). However, Knarreborg et al. (9) challenged his hypothesis, proposing that AGPs primarily interact with host-immune cells rather than directly inhibiting microbiota. AGPs may mitigate inflammation and cytokines release, which otherwise suppress appetite and increase muscle catabolism (Figure 1), thereby improving energy utilization and growth efficiency (10). Advances in molecular biology and bioinformatics indicate that AGPs modulate gut-microbiota (11), reduce inflammation, enhance nutrient absorption, and optimize growth performance (12). Specifically, Lin (13) demonstrated that AGPs decrease bile salt hydrolase (BSH) – producing bacterial, altering bile acid metabolism and host lipid utilization.

Figure 1
Flowchart illustrating the impact of flavonoids and probiotics on animal growth and health. Flavonoids stimulate probiotic microbes like Lactobacillus, improving microbial balance. Improved microbiota ferments to produce lactic acid and short-chain fatty acids (SCFAs), enhancing tight junction proteins and permeability. The cycle promotes growth, productivity, and immunity. Antibiotics alter microbiota composition, while probiotics reintroduce beneficial microbes, fostering improvements in feed conversion ratio (FCR) and overall animal health.

Figure 1. Multifunctional role of Lactobacillus and other probiotics in gut homeostasis. Probiotics antagonize pathogens via the secretion of antibacterial agents and organic acids, modulate the host’s microbiota, fostering a symbiotic community that produces health-promoting metabolites like SCFAs. Strengthen gut epithelial barrier for intestinal permeability and reduced inflammation.

Mouse studies reveal that sub-therapeutic antibiotics reshape gut microbiota composition, favoring microbes with enhanced carbohydrate-to-SCFA (short chain fatty acids) metabolic pathways (14). Notably, this growth-promoting phenotype was transmissible to germ-free hosts, confirming microbiota-mediated effects rather than direct antibiotic action. Early-life low-dose antibiotic exposure also induces lasting metabolic changes by accelerating age-related microbiota shifts and altering ileal immune gene expression (15). While findings in rodents may not directly translate to livestock, they provide insights into potential AGP mechanisms.

Classes of antibiotic alternatives

An ideal AGPs should enhance nutrient absorption, maximize animal performance, and replicate AGP benefits (12). Effective substitutes must also modulate immunity while improving feed efficiency and growth, aligning with proposed AGP mechanisms (16). In poultry production, tested alternatives include probiotics, prebiotics, phytobiotics, bacteriophages, synbiotics, organic acids, enzymes, phytogenics, and metals (17). Emerging options – such as hyperimmune egg yolk IgY (18), antibacterial peptides (AMP) (19), bacteriophages (20), and clay minerals (21) – have also gained attention for their potential as AGP replacements.

Probiotics

Probiotics or direct-fed microbial (DFMs) represent one of the most promising alternatives to AGPs (22). When administered in feed – either alone or in combination with other additives – probiotics confer health benefits to the host (Figure 2). Probiotics are administered in-ovo or spraying on 1 day old chicks (23). Livestock probiotics primarily utilize Bacillus, Bifidobacterium, Enterococcus, Lactobacillus, Streptococcus, Lactococcus, and Saccharomyces spp. (24, 25). Lactobacillus strains (single or multi-strain) improve animal body weight and feed conversion ratio (FCR) (26). Bacillus coagulans, Bacillus subtilis, Bacillus licheniformis, and Bacillus amyloliquefaciens boost productivity (27). Other effective probiotic strains are Rhodopseudomonas palustris (28), Enterococcus faecium (29), and Clostridium butyricum (30). Spray application by Faria Filho et al. (31) reported a 0.14 increase in body weight and 0.10-point FCR reduction across 27 Brazilian trials. Similarly, spray application by Blajman et al. (32) confirmed improved FCR and weight gain, noting superior efficacy when administered via water versus feed.

Figure 2
Diagram illustrating the role of probiotics in gut health. Central illustration of intestines encircled by text:

Figure 2. Dual-pathway model of probiotic function. (1) Competitive exclusion – involving pathogen inhibition via antimicrobial activity, ammonia reduction, and pH control; and (2) Host interaction, enhances barrier function, provides enzymatic and nutritional support, and stimulates immune responses.

Probiotics enhance performance through microbial modulation, gut health, immune enhancement, and nutrient utilization (33). In microbial modulation, competitive exclusion of pathogens, production of antimicrobial compounds against pathogens (e.g., bacteriocins, SCFAs), and pH reduction (34). Probiotics improve gut health which plays pivotal role in improvement of villus height, crypt depth (35), and enrichment of beneficial microbiota such as Lactobacillus and Bifidobacterium (36). Probiotics improve livestock immunity by elevating secretory IgA, macrophage activation, and cytokine production (37) as well as enhance digestive enzyme activity and reduce anti-nutritional compounds (38). Efficacy of probiotics varies by strain, dosage, and environmental factors (39). Optimal probiotic strains must resist gastric acidity, adhere to intestinal epithelium, and exhibit immunomodulatory properties (40). To ensure viability and colonization in the intestine encapsulation techniques such as micro-encapsulation can improve viability of probiotics (41). Despite benefits, the propensity of probiotic Enterococcus and Lactobacillus strains for horizontal gene transfer (HGT), mediated by their mobile genetic elements (MGEs), poses a significant risk of amplifying the gut resistome demanding rigorous safety screening before commercialization of probiotic strains (42).

Prebiotics

Prebiotics or fermentable oligosaccharides constitute a well-established alternative to AGPs (43). When incorporated into feed—either as standalone supplements or synergistically with probiotics, prebiotics selectively modulate intestinal microbial composition by selectively stimulating commensal bacterial growth enhancing host health and performance (Figure 3). Prebiotics are non-digestible feed components that confer health benefits by selectively stimulating the growth or activity of beneficial intestinal bacteria (44, 45). These compounds, primarily non-starch polysaccharides (NSP) or oligosaccharides (β-glucans)—including mannan-oligosaccharides (MOS) (46), fructo-oligosaccharides (FOS) (47), galactooligosaccharides (GOS) (48), lactulose (49), arabinoxylans (50), xylooligosaccharides (XOS) (51), isomalto-oligosaccharides (IOS) (52), and inulin (53) – are derived from microbial or plant sources which selectively enhance beneficial gut microbiota (Figure 4). Yeast cell-wall supplements relatively raised body weight by 1.61% and reduced FCR by 1.99% (54). Prebiotics administration relatively improved body weight (5.41%), FCR (2.54%), and mortality rates (10.5%) (55).

Figure 3
Flowchart illustrating the impact of non-antibiotics and antibiotics on the chicken microbiome. Non-antibiotics like probiotics and bacteriophages promote homeostasis, reducing disease incidence and improving productivity. This supports dominant bacteria like Firmicutes, Bacteroidetes, and Proteobacteria. Antibiotics, associated with dysbiosis, reduce microbial diversity and probiotic density, leading to pathogenic bacteria such as Campylobacter, Salmonella, and Escherichia. All elements converge at gut microbiota.

Figure 3. Schematic representation of factors modulating gut microbiome and consequent health out-comes. Chicken microbiome is dominated by Firmicutes (78%), Bacteroidetes (11%), and Proteobacteria (4%). Probiotics, prebiotics, phytobiotics, and bacteriophages maintain homeostasis by outcompeting pathogens resulting in improved disease resistance and productivity. While broad-spectrum antibiotics depletes beneficial microbes.

Figure 4
Diagram illustrating alternatives to antibiotics in poultry. The central section highlights a chicken with branches indicating categories: dietary organic acids, probiotics, prebiotics, synbiotics, clay and trace minerals, bacteriophage, antimicrobial peptides, genomic medicines, and phyogenic feed additives. Each section details benefits like weight gain, digestive improvement, metabolism enhancement, cell lysis by bacteriophages, and antimicrobial properties. Icons and labels represent elements like enzymes, fish pellets, essential oils, clay minerals, and gene editing.

Figure 4. Comprehensive schematic overview of antibiotic alternatives in poultry production. Enzymes (e.g., xylanase, cellulase) counteract anti-nutritional factors; dietary organic acids, probiotics, prebiotics, and synbiotics foster beneficial microbiota; clay and trace minerals support microbial and metabolic functions; bacteriophages kill pathogens to balance microbiota; antimicrobial peptides disrupt membranes of pathogens; genomic medicines enable disease resistance through gene editing; phytogenic additives boost natural growth and immune support; and essential oils delivering antimicrobial and antioxidant effects, collectively improve feed efficiency and gut health resulted in more weight gain.

Prebiotics enhance livestock performance through microbial modulation, metabolic effects, and immunomodulation (56). MOS is derived from Saccharomyces cerevisiae cell walls, acts as a pathogen-associated molecular pattern (PAMP), triggering innate immune responses (57), enhances body weight gain, FCR, intestinal villus height (58, 59), and immune competence (60). FOS improves broiler efficiency (61), while IOS enhance weight gain and FCR (26). Lactulose supplementation increases body weight, FCR, villus height, goblet cell density, SCFA production, and Lactobacillus populations (62, 63). Fermentation yields SCFAs (e.g., acetate, butyrate), which fuel enterocytes and maintain gut barrier integrity (57). Ideal prebiotics must resist gastric acidity, evade enzymatic hydrolysis, and avoid mucosal absorption (64).

Synbiotics

Synbiotics, defined as nutritional supplements combining probiotics and prebiotics, function synergistically to enhance host health by improving probiotic survival, implantation, and the selective stimulation of beneficial intestinal bacteria (65). Dietary supplementation with synbiotics has been shown to increase body weight, average growth rate, feed efficiency, and carcass yield compared to control or probiotic-only diets (66). Further corroborating these findings, Boostani et al. (67) reported similar growth improvements, while Mohnl et al. (68) observed a 2.04% increase in body weight and a 0.9% reduction in mortality. Mookiah et al. (26) noted enhanced weight gain and reduced FCR in birds fed a symbiotic blend of 11 Lactobacillus strains, and isomalto-oligosaccharides (IOS), though no twofold synergistic effect was observed compared to individual components. Yitbarek et al. (69) documented greater weight gain in pullets supplemented with probiotics and yeast-derived carbohydrates versus prebiotic-only or control group. However, some studies found no significant performance improvement with synbiotic inclusion (70). Beyond growth metrics, synbiotic have been shown to enhance gut morphology, increasing villus height and crypt depth (71). Their potential as antibiotic alternatives in poultry production lies in optimizing performance and reducing intestinal pathogen load. Nevertheless, careful selection of compatible prebiotic-probiotic combinations and rigorous validation of synergistic efficacy – relative to standalone use – are essential for maximizing their benefits.

Dietary organic acids (DOAs)

Dietary organic acids (DOAs) are historically recognized as antimicrobial agents and considered viable alternatives for AGPs in livestock production. Chemically, these acids are classified as either mono-carboxylic acids (e.g., formic, acetic, propionic, butyric) or hydroxyl-group-containing carboxyl groups (Table 1) (72). Naturally occurring in plant and animal tissues, some – particularly short-chain fatty acids (SCFA) – are also produced in the hindgut through microbial fermentation of carbohydrates (73). DOAs can be administered via feed or water, either as free acids, salts, or blended formulations (12). Supplementation with fumaric acid improved feed efficiency and weight gain in broilers (74), while butyric acid enhanced growth rates (75). Other DOAs are citric (76), formic (77), malic (78), sorbic (79), and tartaric acids (80), have also demonstrated efficacy in livestock. Blends (OABs) leverage synergy, broader spectrum of activity, and yield superior results as compared to single DOA. For example, chromium OAB improved broiler meat quality by decreasing fat content per 100 g of carcass, increased total ash and protein accretion, high plasma chromium concentration, reduced pH in the gizzard and duodenum, and deposition of chromium in breast and thigh as compared to single DOA administration (81).

Table 1
www.frontiersin.org

Table 1. Organic acids as alternative to antibiotics.

The antimicrobial mechanisms of DOAs, though not fully elucidated, may involve lowering gastrointestinal pH, altering stomach mucosa physiology (77), modulating gut microbiota by directly suppressing pathogens (via cell-wall penetration) or indirectly favoring acid-tolerant beneficial bacteria (Lactobacillus) while reducing nutrient competition (82), enhancing nutrient digestibility through improved enzyme activity (83), promoting gut health via direct epithelial stimulation (e.g., SCFAs as an energy source for enterocyte proliferation). Despite their benefits, inconsistent efficacy, palatability and stability attributed to factors such as inclusion rates, organic acid sources, and dietary buffering capacity (84). For example, formic, propionic, acetic and butyric acids have pungent smell and low palatability and stability while lactic acid has better palatability and stability (85). Formulation of OABs by addition of salts such as calcium formate and potassium sorbate mask pungent smell and deliver the benefits of DOAs without palatability drawbacks (86). Further research is needed to optimize their use and establish reliable mechanisms of action, ensuring their effectiveness as sustainable antibiotic alternatives.

Dietary enzymes (DEs)

Dietary enzymes are biologically active proteins that catalyze the breakdown of complex nutrients into absorbable components, enhancing digestive efficiency and nutrient utilization (87). Primarily derived from microbial fermentation, these exogenous enzymes – including phytases, carbohydrates (xylanase, cellulase, α-galactosidase, β-mannanase, α-amylase, pectinase), and proteases – are widely employed in swine diets. Their primary role involves counteracting anti-nutritional factors (ANFs) inherent in plant-based feed ingredients, such as phytic acid, non-starch polysaccharides (NSP), and cell-wall complexes, thereby improving nutrient bioavailability (88). Meta-analysis revealed mixture of phytase and NSP-degrading enzymes increased body weight by 3.73% and reduced FCR by 2.64% (89). Similarly, β-mannanase supplementation improved weight by 4.8% and FCR by 4.2 points in market-age broilers (90). Combined xylanase, amylase, and protease enhanced crude protein, starch, and fat digestibility by 22.7, 88.9, and 33.4%, respectively (91). Dietary enzymes represent a promising alternative to antibiotics, enhancing nutrient utilization and gut health. However, optimizing their application requires tailored formulations to account for dietary and biological variability (40). Further research should focus on standardized protocols to maximize consistency in poultry production systems.

The efficacy of in-feed enzymes is attributed to disruption of cell-wall matrices, hydrolysis of indigestible substages, inactivation of ANFs, solubilization of insoluble NSPs, and modulation of gut microbiota (92). Dietary enzymes break cell wall to liberate encapsulated starch, animo acids, and minerals and hydrolyze phytate-P by phytase (92). Dietary enzymes reduce interference of ANFs with nutrient absorption, enhance cecal fermentation of NSPs and SCFA production as well as alter microbial ecology via generation of prebiotic OS and reduction of undigested substrates (40).

Phytogenic feed additives (PFAs)

Phytogenic feed additives (PFAs) are comprised of bioactive plant-derived compounds incorporated into livestock diets to enhance productivity (93). PFAs are antimicrobial, antioxidant, immunomodulation, digestive enhancement and play key role in gut morphology optimization (94). PFAs directly inhibit pathogens and gut microbiota modulation, reducing microbial toxins and intestinal immune stress (95). Their antioxidative property mitigates oxidative stress, and improve tissue health (96). PFAs augment cytokine production, antibody titers, and immune cell proliferation (97). PFAs improve nutrients digestion via stimulation of pancreatic enzyme secretion, and bile flow (98, 99). Similarly, PFAs increase villus height and transepithelial resistance, improving nutrient absorption and barrier integrity (100, 101). PFAs are derived from thyme, oregano, rosemary, garlic, ginger, cinnamon, and green tea (Table 2). Based on extraction methodology, PFAs are classified as essential oils (e.g., volatile lipophilic compounds obtained via steam/alcohol distillation or cold extraction) and oleoresins (non-aqueous solvent-derived extracts rich in bioactive constituents) (Figure 4) (102). The efficacy of PFAs hinges on their polyphenolic composition, which verities with plant species, anatomical part, geographic origin, harvest timing, storage conditions, and processing techniques (103).

Table 2
www.frontiersin.org

Table 2. Active compounds of various herbal plants and their antimicrobial activity.

PFAs have gained traction in livestock production as natural alternatives to antibiotic growth promoters (AGPs). For example, a 14-herb mixture significantly improved broiler weight gain and feed efficiency (104). Black cumin (Nigella sativa), Scrophularia striata, and Ferulago angulata demonstrated growth-promoting effects (Table 2) (105). Sugar cane, aniseed, chestnut wood, and Portulaca oleracea extracts enhanced body weight gain and reduced FCR (106). Conversely, certain PFAs—such as grape pomace, cranberry extract, and Macleaya cordata—showed no measurable impact on performance metrics (107). EOs contain thymol, carvacrol, cinnamaldehyde, and those derived from clove, coriander, and star anise. Thymol-cinnamaldehyde blends (108) and oregano EO (109) improved body weight, and correlated with lower FCR (110). Notably, a commercial PFA blend of carvacrol, cinnamaldehyde, and capsicum oleoresin received EU authorization for broiler performance enhancement, with meta-analyses confirming consistent improvements in weight gain, FCR, and mortality reduction (111, 112). Future research should prioritize elucidating structure–activity relationships and optimizing delivery systems to maximize consistency in livestock production.

Following a ban on AGPs, a Brazilian broiler farm faced high mortality, wet litter, and a poor FCR (113). The introduction of a PFAs (blend of thymol, carvacrol, and cinnamaldehyde) at 150 g/ton of feed resulted in a 4-point FCR improvement (1.68 to 1.64), significantly drier litter, and reduced intestinal lesions, demonstrating enhanced gut health and nutrient digestibility (114). A 1,200-sow operation in Spain faced severe post-weaning diarrhea in piglets, resulting in high mortality, growth checks, and heavy reliance on antibiotics. Pre-weaning liquid supplement with carvacrol and anise oil from day five stimulated early gut development, followed by a post-weaning diet for 4 weeks containing a micro-encapsulated PFAs high in carvacrol and cinnamaldehyde resulted in 60% decrease in diarrhea, 12% increase in Average Daily Gain in the first 4 weeks post-weaning, and cut 70% use of antibiotics (115). A 500-cow US dairy farm feed blend of PFAs (capsicum, cinnamaldehyde, and eugenol) to the total mixed ration resulted in selectively inhibiting lactate-producing bacteria to stabilize rumen pH and enrich the population of fibrolytic bacteria. The enhanced ruminal environment directly boosted productivity, increased average milk yield by 1.5 kg/cow/day and 0.3% increase in milk fat (258). The economic return from these performance gains fully offset the additive’s cost, providing a viable non-antibiotic strategy to restore profitability. Although, PFAs are low risk to drive AMR, but some bacteria can develop non-genetical tolerance through general response pathways, efflux pump upregulation, or biofilm formation which may result in the selection of more broadly resistant strains.

Hyperimmune egg yolk antibodies (HEYAs)

Hyperimmune egg yolk antibodies (IgY), produced by repeatedly immunizing layers with specific antigens and subsequently harvesting antibodies from their yolks, are commonly employed in preventing and treating various enteric diseases in animals (116). However, limited research on their efficacy as antibiotic growth promoter (AGP) alternatives for enhancing poultry growth and feed efficiency (117). In livestock, maternal antibodies transfer to offspring to improve productivity. Pimentel et al. (118) observed increased body weight in three-week-old chicks from hens injected with jack bean urease, suggesting that maternally derived urease antibodies may enhance growth by inhibiting bacterial urease and reducing intestinal ammonia production. With advancements in IgY technology, subsequent research explored dietary antibody supplementation to enhance host immunity or performance (Table 3) (119). Many studies utilized antibodies targeting immune-modulatory molecules, given that immune activation suppresses growth—likely due to inflammation-induced release of anorexigenic neuropeptides like cholecystokinin (CCK) and neuropeptide Y (NPY) (120).

Table 3
www.frontiersin.org

Table 3. Hyperimmune egg antibodies as alternative antimicrobials.

Cook (117) demonstrated that feeding broilers with non-approved HEYA powder at the rate of 2% against Cholecystokinin (CCK) or neuropeptide Y (NPY) for 3 weeks improved body weight and feed efficiency. Specifically, dietary inclusion of CCK antibody-enriched egg powder (0.25 g/kg) enhanced FCR by 13 points compared to controls (Figure 5). Similar improvements were noted in chicks fed at 2% NPY antibody powder namely NovaGrow®, a FDA approved safe feed for animals, showing a 9% increase in weight gain and an 8-point improvement in FCR by 3 weeks (117). Supplementing diets with 0.1% BIG™ (Bio-Immunoglobulin), approved and commercially available, targeting phospholipase A2—an enzyme involved in pro-inflammatory eicosanoid synthesis—for 3 weeks increased broiler weight gain by 5.4% and improved FCR by 6.2 points (117). IgY technology offers several advantages: high-yield antibody production in hens, non-invasive collection, low toxicity, environmental compatibility, and no risk of resistance development. Despite promising preliminary results, further research is necessary before implementing egg antibodies as a growth-enhancing strategy in poultry.

Figure 5
Flowchart illustrating the production of powdered IgY products. Specialized feed formulation enriched with biotin is given to chickens, impacting layers and health metrics. Outcomes include feed conversion ratio, immune response rate, and growth rate. Layers produce enriched eggs, followed by yolk separation and purification to produce purified yolk antibodies IgY. This is processed into a powdered IgY product, leading to a veterinary health supplement, depicted with cow figures.

Figure 5. Value-added eggs as therapeutic antibodies. Eggs yolks of hens fed on biotin-enriched specialized diet are rich in IgY and used as veterinary health supplements or passive immunization therapies.

Genomic medicines (GMs)

Growing global concern over antibiotic resistance in livestock production have spurred the exploration of alternative strategies. Among the most significant advancements is the application of genomic medicine—leveraging molecular-level insights to diagnose, understand, and manipulate biological systems in animals. This field encompasses gene editing (e.g., CRISPR/Cas9), genome-wide association studies (GWAS), transcriptomic profiling, and vaccinomics (Table 4), all aimed at enhancing disease resistance, improving vaccine efficacy, and reducing reliance on antibiotics (121). A key application of genomic medicine is the identification and selection of genetically disease-resistant animals. By pinpointing favorable alleles associated with resistance to pathogens such as E. coli, Salmonella, or Clostridium perfringens (122, 123), breeders can integrate these traits into selection programs, fostering herd immunity. This approach reduces disease prevalence, diminishes the need for prophylactic or therapeutic antibiotics, and supports One Health-oriented, sustainable animal production.

Table 4
www.frontiersin.org

Table 4. Genomic medicine as an alternative to antibiotics in poultry and livestock production.

Furthermore, gene-editing technologies like CRISPR enable direct genome modifications to enhance immunity or disrupt pathogen replication. For example, editing the CD163 gene in experimental pigs has conferred resistance to porcine reproductive and respiratory syndrome (PRRS), a disease historically controlled with antibiotics (124, 125). Similar strategies are being investigated in poultry to combat necrotic enteritis and avian influenza, offering precise, permanent solutions to infectious diseases without environmental trade-offs. Additionally, vaccinomics—guided by immune response network theory—facilitates the development of tailored vaccines optimized for specific breeds or regional pathogens (126). These next-generation vaccines induce stronger, more targeted immune responses, reducing the incidence and severity of bacterial infections in livestock and poultry (127). When integrated with precision livestock farming, genomic medicine paves the way for a more resilient, antibiotic-independent production system.

Antimicrobial peptides (AMPs)

AMPs are small, gene-encoded germicidal molecules which exhibit broad-spectrum activity against diverse pathogens, including bacteria, fungi, parasites, and enveloped viruses (128). Mature AMPs typically comprise 12–100 amino acids, characterized by cationic and hydrophobic residues that confer an amphipathic structure, enabling interactions with negatively charged microbial membranes and other cellular targets (Figure 6). Over 2,600 endogenous AMPs have been identified, alongside numerous synthetic analogues (APS Database)1 (129). While research on AMPs in livestock has predominantly focused on their defensive role against infectious pathogens, emerging studies suggest their potential as alternatives to AGPs. For instance, dietary supplementation with the chimeric peptide cecropin A (1–11)-D(12–37)-Asn (CADN) enhanced weight gain, feed efficiency, jejunal and cecal villus height, and reduced aerobic bacterial counts in digesta (130). Similarly, the CAMA peptide (a cecropin A-magainin 2 hybrid) improved growth performance, nutrient retention, gut morphology, and microbiota composition (Figure 3) (131). Naturally derived AMPs—isolated from porcine intestines or rabbit sacculus rotundus—also enhanced growth, nutrient absorption, and mucosal immunity (e.g., secretory IgA and intraepithelial lymphocytes) in poultry (132).

Figure 6
Diagram illustrating the mechanism and effects of antimicrobial peptides (AMPs). The process starts with peptide binding to bacteria (1), causing membrane disruption (2), leading to intracellular interaction (3), cell lysis (4), and cell death (5). Resulting enhancements include improved immunity and gut health, leading to increased growth rates in ovine, bovine, and avian species.

Figure 6. Antimicrobial peptides (AMPs) in livestock production. Antimicrobial peptides are immuno-modulators which degrade outer membrane and disrupt intracellular mechanisms of pathogens to avoid disease incidence. So, AMPs foster a healthy gut environment, improve growth performance and feed efficiency in household animals.

Bacteriocins, a subclass of AMPs, are ribosomally synthesized antimicrobial peptides produced by bacteria and archaea, exhibit narrow-spectrum activity against phylogenetically related strains. Initially recognized as food preservatives, they are now considered pivotal in probiotic selection (133). To date, 177 bacteriocins from 31 bacterial and archaeal species have been documented (BACTIBASE).2 For example, Divercin AS7 (Carnobacterium divergens) is in research phase and not commercially approved for food or feed which has shown improved growth efficiency, nutrient digestibility, and gut microbiota balance while reducing digesta pH in broiler at the rate of 107 CFU/g of feed (134). Similarly, Nisin (Nisaplin®, Lactococcus lactis) is FDA-approved bacteriocin for food not feed, it modulated gut microbiota by suppressing Bacteroides and Enterobacteriaceae without affecting Lactobacillus or Clostridium perfringens at the rate of 3,000 mg/kg diet (135). Albusin B (Ruminococcus albus) is another non-approved prebiotic which enhanced growth performance, lipid metabolism, antioxidant capacity, and Lactobacillus proliferation in broiler at the rate of 3% of the diet (136, 137). Although AMPs demonstrate promise in replacing AGPs, but their production cost is very high, may have potential resistance development by microbes altering surface charge, enacting proteolytic degradation, and upregulating efflux pumps. Consequently, the utilization of AMPs as growth promoters risks inadvertently selecting for strains with enhanced virulence and broadened intrinsic resistance, thereby compromising both innate immunity and last-line antibiotic therapies.

Bacteriophages

Bacteriophages are highly specific viruses that exclusively infect and lyse bacterial cells through the production of endolysins, while remaining inert to eukaryotic cells in plants and animals. Their precise bactericidal activity has led to applications in both prophylactic and therapeutic interventions against bacterial infections in humans and livestock (138). Extensive research has demonstrated their efficacy in controlling foodborne pathogens within agricultural production systems (139). Emerging evidence suggests potential growth-promoting effects when incorporated into poultry diets. In laying hens, dietary supplementation with zootechnical approved feed additive namely Bafasal®, a Salmonella-targeting bacteriophages cocktail, at the rate of 0.035–0.05% (350–500 g/metric ton of feed) significantly enhanced egg production (140). Similarly, broilers receiving 0.10–0.15% of lytic bacteriophage cocktail targeting Salmonella enterica serovar Enteritidis feed supplementation, and 0.5 g/kg bacteriophage cocktail targeting Clostridium perfringens feed formulations exhibited significantly improved body weight gain and FCR (Table 5) (141, 142). SalmoFresh® by Intralytix3 and Preforpro® by Deerland Probiotics and Enzymes4 are FDA approved for food and feed additive for poultry, human and pets, respectively. While these findings indicate bacteriophages are potential antibiotic alternatives, but their application is very less due to limited host range because few host-phage receptor binding proteins exists. Bacteriophages impose strong selective pressure for the evolution of phage resistant bacteria via modification to cell surface receptors, i.e., lipopolysaccharides and porins. Further investigations are required to fully elucidate the growth-promoting mechanisms of bacteriophages and optimize their practical application in commercial poultry production systems. The regulatory landscape for phage therapy in animals is still evolving due to their variable nature, complex characterization, efficacy trials, intellectual property rights, and environmental impact assessment.

Table 5
www.frontiersin.org

Table 5. Efficacy of various bacteriophages as alternative antimicrobials.

Clay minerals (CMs)

Phyllosilicate clays are layered aluminosilicate minerals composed of tetrahedral and octahedral sheets interconnected through hydrogen bonds or cationic bridges (143). Naturally occurring clays—including bentonite, zeolite, and kaolin—represent complex mixtures of these minerals with heterogeneous chemical compositions (143). Their unique structural properties confer exceptional adsorption capacity, enabling the binding of aflatoxins, enterotoxins, heavy metals, viral particles, and plant metabolites. The extent of adsorption is governed by clay chemistry, particle morphology, surface characteristics, pH, dosage, and exposure duration (87). While extensive research has documented the antimicrobial and detoxification properties of clays in livestock (144), their growth-promoting effects remain less characterized.

Copper-bearing montmorillonite supplementation significantly improved broiler growth performance, reduced E. coli and Clostridium spp. colonization, and enhanced intestinal digestive enzyme activity (145). Similarly, dietary hydrated aluminosilicate (5 g/kg) increased body weight gain and elevated lactate dehydrogenase and amylase activity in broilers (146). Comparable benefits were observed with kaolin, bentonite, and zeolite supplementation (147). Clinoptilolite supplementation enhanced systemic antioxidant status, as evidenced by increased hepatic glutathione peroxidase, catalase, and superoxide dismutase activity, alongside reduced malondialdehyde levels (148). However, growth performance responses have shown variability across studies, with some reporting neutral effects (148). The growth-promoting mechanisms of clay minerals could be due to toxin sequestration, gut function modulation and nutrient utilization (147). Further research is warranted to evaluate clays as viable AGP alternatives and investigate potential synergistic interactions with other feed additives.

Trace minerals (TMs)

Essential trace minerals such as Cu, Zn, Fe, Se, and Mn serve as co-factors for numerous enzymatic and biosynthetic processes which play critical roles in maintaining livestock health and metabolic function directly influencing growth performance and physiological development (149). Traditionally supplemented as inorganic salts (carbonates, chlorides, oxides, sulfates) or organic complexes, their application at supernutrition levels has gained prominence for performance enhancement in modern poultry production. Cu is a vital catalytic element in connective tissue formation, hemoglobin synthesis, and angiogenesis (150), demonstrates significant growth-promoting effects when supplemented at 125–250 mg/kg diet in forms such as sulfate, citrate, or carbonate (151). Comparative bioavailability studies indicate that organic complexes like cupric citrate (resulting in 9.1% weight gain increase) can outperform inorganic sources like cupric sulfate (4.9% increase) in broilers (152), with tribasic copper chloride similarly enhancing daily growth and carcass yield (153).

Zn, an essential micronutrient for cellular proliferation, immune modulation, and oxidative protection (154), has shown variable effects. For instance, ZnSO4 supplementation at 80 mg/kg improved body weight without affecting feed efficiency (155), while other studies report its primary benefits as immunostimulatory rather than directly growth-promoting (156). The antimicrobial properties of both Cu and Zn contribute to their efficacy, modulating gut microbiota by reducing pathogenic and commensal bacterial populations (157). However, mineral supplementation presents environmental pollution such as excessive metal accumulation in soil and water systems (155), coupled with the emergence of metal-resistant enteric bacteria exhibiting cross-resistance to antimicrobials (157). The EU implemented a regulatory ban on pharmacologic Zinc Oxide (ZnO) in livestock feed in 2022 (158), driven by its environmental persistence and role in co-selecting AMR (159), mandates an industry paradigm shift in trace mineral strategy from blunt, high-dose disease control toward precision nutrition that leverages enhanced bioavailability to build host resilience and mitigate these externalities (160).

Conclusion

The growing consumer demand for antibiotic-free animal products has necessitated the development of effective alternative growth promoters (AGPs) capable of maintaining optimal health and production efficiency in food animals. AGPs such as probiotics, prebiotics, synbiotics, dietary organic acids, dietary enzymes, phytogenics, hyperimmune egg yolk antibodies, genomic medicines, antimicrobial peptides, bacteriophages, and clay and trace minerals have demonstrated potential in livestock production. Notably, AGPs such as blended organic acids (BOAs) and trace minerals are highly cost-efficient, probiotics and bacteriophages are moderate to high, bacteriocins are low, hyperimmune egg yolks are low to moderate, and essential oils are variable. Scalability of BOAs, probiotics and minerals is excellent, essential oils and bacteriophages is good, while hyperimmune egg yolk and bacteriocins is poor. One health implications of all AGPs is highly positive except trace minerals which cause environmental pollution. Efficacy of AGPs remain inconsistent, with performance outcomes varying significantly across production systems. This variability underscores the importance of selecting alternatives tailored to specific operational requirements. This further demands mechanistic elucidation – defining precise modes of action to predict and standardize effects, delivery optimization – advancing targeted-release technologies (e.g., microencapsulation) to enhance bioavailability and site-specific activity, and synergistic formulation – evaluating combinatorial approaches to achieve antibiotic-like efficacy through additive or synergistic interactions for antibiotic alternatives. Ultimately, sustainable reductions in antibiotic use will depend on integrating optimized alternative blends with improved management practices, ensuring both animal productivity and welfare in antibiotic-free production systems.

Author contributions

MA: Conceptualization, Data curation, Funding acquisition, Project administration, Resources, Writing – original draft, Writing – review & editing. GA: Conceptualization, Data curation, Writing – original draft. Fatima: Data curation, Software, Writing – original draft. AH: Data curation, Software, Writing – original draft. SJ: Data curation, Software, Writing – original draft. YL: Project administration, Resources, Writing – original draft. GZ: Resources, Writing – original draft. LX: Resources, Supervision, Writing – original draft, Writing – review & editing.

Funding

The author(s) declare that financial support was received for the research and/or publication of this article. This work was supported by the project of Research on the Bio-synthesis of a Long-acting, Highly Active Follicle-Stimulating Hormone (FSH) for Enhanced Ovulation in Dairy Cows, funded by National Center of Technology Innovation for Dairy (No. 2025-QNJJ-010), Research and Development of High Expression and Stable FSH Strains for Biomanufacturing (No. 2025YFHH0267), and the Development of Core Technology and Establishment of Breeding Core Group for High Yield/Disease Resistance/Long Production Period Dairy Cattle Breeding (No. 2024-JSGG-028).

Acknowledgments

We are grateful to kind administration of Inner Mongolia Saikexing Institute of Breeding and Reproductive Biotechnology in Domestic Animal, Hohhot, China for providing us such a prestigious platform to this study.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The authors declare that no Gen AI was used in the creation of this manuscript.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Footnotes

References

1. Castanon, J. History of the use of antibiotic as growth promoters in European poultry feeds. Poult Sci. (2007) 86:2466–71. doi: 10.3382/ps.2007-00249,

PubMed Abstract | Crossref Full Text | Google Scholar

2. Straniero, V. Finding ways to fight antimicrobial resistance: present, future, and perspectives. Antibiotics Basel. (2024) 13:4. doi: 10.3390/antibiotics13020171,

PubMed Abstract | Crossref Full Text | Google Scholar

3. Nety, S, and Aalisha,. A novel alternative therapeutic strategies to tackle antibiotic resistance. Bio Vet Innovator Magazine. (2025) 2:4941. doi: 10.5281/zenodo.15384941

Crossref Full Text | Google Scholar

4. Saab, R. Knowledge, attitudes, and practices of antibiotic use in human health and livestock management: Implications for public health, sustainability, and antibiotic resistance. Doctor of Education. Lubbock, TX: Texas Tech University (2024).

Google Scholar

5. Quaik, S, Embrandiri, A, Ravindran, B, Hossain, K, Al-Dhabi, NA, Arasu, MV, et al. Veterinary antibiotics in animal manure and manure laden soil: scenario and challenges in Asian countries. J King Saud Univ Sci. (2020) 32:1300–5. doi: 10.1016/j.jksus.2019.11.015

Crossref Full Text | Google Scholar

6. Geneva, W. Global HIV/AIDS response: Epidemic update and health sector progress towards universal access: Progress report. Switzerland: World Health Organization (2011).

Google Scholar

7. Tajkarimi, M, Ibrahim, SA, and Cliver, D. Antimicrobial herb and spice compounds in food. Food Control. (2010) 21:1199–218. doi: 10.1016/j.foodcont.2010.02.003

Crossref Full Text | Google Scholar

8. Watson, MD, Cross, BL, and Grosicki, GJ. Evidence for the contribution of gut microbiota to age-related anabolic resistance. Nutrients. (2021) 13:706. doi: 10.3390/nu13020706,

PubMed Abstract | Crossref Full Text | Google Scholar

9. Knarreborg, A, Lauridsen, C, Engberg, RM, and Jensen, SK. Dietary antibiotic growth promoters enhance the bioavailability of α-tocopheryl acetate in broilers by altering lipid absorption. J Nutr. (2004) 134:1487–92. doi: 10.1093/jn/134.6.1487,

PubMed Abstract | Crossref Full Text | Google Scholar

10. Niewold, T. The nonantibiotic anti-inflammatory effect of antimicrobial growth promoters, the real mode of action? A hypothesis. Poult Sci. (2007) 86:605–9. doi: 10.1093/ps/86.4.605,

PubMed Abstract | Crossref Full Text | Google Scholar

11. Lin, J, Hunkapiller, AA, Layton, AC, Chang, YJ, and Robbins, KR. Response of intestinal microbiota to antibiotic growth promoters in chickens. Foodborne Pathog Dis. (2013) 10:331–7. doi: 10.1089/fpd.2012.1348,

PubMed Abstract | Crossref Full Text | Google Scholar

12. Huyghebaert, G, Ducatelle, R, and Van Immerseel, F. An update on alternatives to antimicrobial growth promoters for broilers. Vet J. (2011) 187:182–8. doi: 10.1016/j.tvjl.2010.03.003,

PubMed Abstract | Crossref Full Text | Google Scholar

13. Lin, J. Antibiotic growth promoters enhance animal production by targeting intestinal bile salt hydrolase and its producers. Front Microbiol. (2014) 5:33. doi: 10.3389/fmicb.2014.00033,

PubMed Abstract | Crossref Full Text | Google Scholar

14. Cho, I, Yamanishi, S, Cox, L, Methé, BA, Zavadil, J, Li, K, et al. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature. (2012) 488:621–6. doi: 10.1038/nature11400,

PubMed Abstract | Crossref Full Text | Google Scholar

15. Cox, LM, Yamanishi, S, Sohn, J, Alekseyenko, AV, Leung, JM, Cho, I, et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell. (2014) 158:705–21. doi: 10.1016/j.cell.2014.05.052,

PubMed Abstract | Crossref Full Text | Google Scholar

16. Seal, BS, Lillehoj, HS, Donovan, DM, and Gay, CG. Alternatives to antibiotics: a symposium on the challenges and solutions for animal production. Anim Health Res Rev. (2013) 14:78–87. doi: 10.1017/S1466252313000030,

PubMed Abstract | Crossref Full Text | Google Scholar

17. Abd El-Hack, ME, El-Saadony, MT, Salem, HM, El-Tahan, AM, Soliman, MM, Youssef, GB, et al. Alternatives to antibiotics for organic poultry production: types, modes of action and impacts on bird's health and production. Poult Sci. (2022) 101:101696. doi: 10.1016/j.psj.2022.101696,

PubMed Abstract | Crossref Full Text | Google Scholar

18. Wang, H, Zhong, Q, and Lin, J. Egg yolk antibody for passive immunization: status, challenges, and prospects. J Agric Food Chem. (2023) 71:5053–61. doi: 10.1021/acs.jafc.2c09180,

PubMed Abstract | Crossref Full Text | Google Scholar

19. Seyfi, R, Kahaki, FA, Ebrahimi, T, Montazersaheb, S, Eyvazi, S, Babaeipour, V, et al. Antimicrobial peptides (AMPs): roles, functions and mechanism of action. Int J Pept Res Ther. (2020) 26:1451–63. doi: 10.1007/s10989-019-09946-9

Crossref Full Text | Google Scholar

20. Kasman, LM, and Porter, LD. Bacteriophages In: StatPearls. Treasure Island (FL): StatPearls Publishing (2022)

Google Scholar

21. Bergaya, F, and Lagaly, G. General introduction: clays, clay minerals, and clay science. Dev Clay Sci. (2006) 1:1–18. doi: 10.1016/S1572-4352(05)01001-9

Crossref Full Text | Google Scholar

22. Lee, K, Lillehoj, HS, and Siragusa, GR. Direct-fed microbials and their impact on the intestinal microflora and immune system of chickens. J Poult Sci. (2010) 47:106–14. doi: 10.2141/jpsa.009096

Crossref Full Text | Google Scholar

23. Cox, C, and Dalloul, R. Immunomodulatory role of probiotics in poultry and potential in ovo application. Benefic Microbes. (2015) 6:45–52. doi: 10.3920/BM2014.0062,

PubMed Abstract | Crossref Full Text | Google Scholar

24. Lambo, MT, Chang, X, and Liu, D. The recent trend in the use of multistrain probiotics in livestock production: An overview. Animals. (2021) 11:2805. doi: 10.3390/ani11102805,

PubMed Abstract | Crossref Full Text | Google Scholar

25. Lutful Kabir, S. The role of probiotics in the poultry industry. Int J Mol Sci. (2009) 10:3531–46. doi: 10.3390/ijms10083531,

PubMed Abstract | Crossref Full Text | Google Scholar

26. Mookiah, S, Sieo, CC, Ramasamy, K, Abdullah, N, and Ho, YW. Effects of dietary prebiotics, probiotic and synbiotics on performance, caecal bacterial populations and caecal fermentation concentrations of broiler chickens. J Sci Food Agric. (2014) 94:341–8. doi: 10.1002/jsfa.6365,

PubMed Abstract | Crossref Full Text | Google Scholar

27. Park, J, and Kim, I. Supplemental effect of probiotic Bacillus subtilis B2A on productivity, organ weight, intestinal Salmonella microflora, and breast meat quality of growing broiler chicks. Poult Sci. (2014) 93:2054–9. doi: 10.3382/ps.2013-03818,

PubMed Abstract | Crossref Full Text | Google Scholar

28. Xu, Q, Yan, H, Liu, X, Lv, L, Yin, C, and Wang, P. Growth performance and meat quality of broiler chickens supplemented with Rhodopseudomonas palustris in drinking water. Br Poult Sci. (2014) 55:360–6. doi: 10.1080/00071668.2014.903326,

PubMed Abstract | Crossref Full Text | Google Scholar

29. Samli, HE, Senkoylu, N, Koc, F, Kanter, M, and Agma, A. Effects of Enterococcus faecium and dried whey on broiler performance, gut histomorphology and intestinal microbiota. Arch Anim Nutr. (2007) 61:42–9. doi: 10.1080/00071668.2010.507241

Crossref Full Text | Google Scholar

30. Liao, X, Ma, G, Cai, J, Fu, Y, Yan, X, Wei, X, et al. Effects of Clostridium butyricum on growth performance, antioxidation, and immune function of broilers. Poult Sci. (2015) 94:662–7. doi: 10.3382/ps/pev038,

PubMed Abstract | Crossref Full Text | Google Scholar

31. Faria Filho, DE, Torres, K, Faria, DEd, Campos, D, and Rosa, P. Probiotics for broiler chickens in Brazil: systematic review and meta-analysis. Revista Brasileira de Ciência Avícola. (2006) 8:89–98. doi: 10.1590/S1516-635X2006000200004

Crossref Full Text | Google Scholar

32. Blajman, JE, Frizzo, LS, Zbrun, MV, Astesana, DM, Fusari, ML, Soto, LP, et al. Probiotics and broiler growth performance: a meta-analysis of randomised controlled trials. Br Poult Sci. (2014) 55:483–94. doi: 10.1080/00071668.2014.931930,

PubMed Abstract | Crossref Full Text | Google Scholar

33. Jha, R, Das, R, Oak, S, and Mishra, P. Probiotics (direct-fed microbials) in poultry nutrition and their effects on nutrient utilization, growth and laying performance, and gut health: a systematic review. Animals. (2020) 10:1863. doi: 10.3390/ani10101863,

PubMed Abstract | Crossref Full Text | Google Scholar

34. Lee, K, Lee, S, Lillehoj, H, Li, G, Jang, S, Babu, U, et al. Effects of direct-fed microbials on growth performance, gut morphometry, and immune characteristics in broiler chickens. Poult Sci. (2010) 89:203–16. doi: 10.3382/ps.2009-00418,

PubMed Abstract | Crossref Full Text | Google Scholar

35. Sen, S, Ingale, S, Kim, Y, Kim, J, Kim, K, Lohakare, J, et al. Effect of supplementation of Bacillus subtilis LS 1-2 to broiler diets on growth performance, nutrient retention, caecal microbiology and small intestinal morphology. Res Vet Sci. (2012) 93:264–8. doi: 10.1016/j.rvsc.2011.05.021,

PubMed Abstract | Crossref Full Text | Google Scholar

36. Zhang, Z, and Kim, I. Effects of multistrain probiotics on growth performance, apparent ileal nutrient digestibility, blood characteristics, cecal microbial shedding, and excreta odor contents in broilers. Poult Sci. (2014) 93:364–70. doi: 10.3382/ps.2013-03314,

PubMed Abstract | Crossref Full Text | Google Scholar

37. Lee, KW, Li, G, Lillehoj, HS, Lee, SH, Jang, SI, Babu, US, et al. Bacillus subtilis-based direct-fed microbials augment macrophage function in broiler chickens. Res Vet Sci. (2011) 91:e87–91. doi: 10.1016/j.rvsc.2011.01.018,

PubMed Abstract | Crossref Full Text | Google Scholar

38. Wang, Y, and Gu, Q. Effect of probiotic on growth performance and digestive enzyme activity of arbor acres broilers. Res Vet Sci. (2010) 89:163–7. doi: 10.1016/j.rvsc.2010.03.009,

PubMed Abstract | Crossref Full Text | Google Scholar

39. Waititu, S, Yitbarek, A, Matini, E, Echeverry, H, Kiarie, E, Rodriguez-Lecompte, J, et al. Effect of supplementing direct-fed microbials on broiler performance, nutrient digestibilities, and immune responses. Poult Sci. (2014) 93:625–35. doi: 10.3382/ps.2013-03575,

PubMed Abstract | Crossref Full Text | Google Scholar

40. Cheng, G, Hao, H, Xie, S, Wang, X, Dai, M, Huang, L, et al. Antibiotic alternatives: the substitution of antibiotics in animal husbandry? Front Microbiol. (2014) 5:217. doi: 10.3389/fmicb.2014.00217,

PubMed Abstract | Crossref Full Text | Google Scholar

41. Han, W, Zhang, X, Wang, D, Li, L, Liu, G, Li, A, et al. Effects of microencapsulated Enterococcus fecalis CG1. 0007 on growth performance, antioxidation activity, and intestinal microbiota in broiler chickens. J Anim Sci. (2013) 91:4374–82. doi: 10.2527/jas.2012-5956,

PubMed Abstract | Crossref Full Text | Google Scholar

42. Radovanovic, M, Kekic, D, Gajic, I, Kabic, J, Jovicevic, M, Kekic, N, et al. Potential influence of antimicrobial resistance gene content in probiotic bacteria on the gut resistome ecosystems. Front Nutr. (2023) 10:1054555. doi: 10.3389/fnut.2023.1054555,

PubMed Abstract | Crossref Full Text | Google Scholar

43. Gibson, GR, and Roberfroid, MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr. (1995) 125:1401–12. doi: 10.1093/jn/125.6.1401,

PubMed Abstract | Crossref Full Text | Google Scholar

44. Joint, F. (2001). Health and nutritional properties of probiotics in food including powder milk with live lave lactic acid bacteria. Ref Tye Report. Available online at: https://who.int/foodsagety/publications/fs_management/en/probiotics.pdf (Accessed March 5, 2024).

Google Scholar

45. Patterson, J, and Burkholder, K. Application of prebiotics and probiotics in poultry production. Poult Sci. (2003) 82:627–31. doi: 10.1093/ps/82.4.627,

PubMed Abstract | Crossref Full Text | Google Scholar

46. Ayimbila, F, and Keawsompong, S. Characteristics and bioactive properties of agro-waste and yeast derived manno-oligosaccharides. Biocatal Agric Biotechnol. (2022) 45:102522. doi: 10.1016/j.bcab.2022.102522

Crossref Full Text | Google Scholar

47. Fanaro, S, Boehm, G, Garssen, J, Knol, J, Mosca, F, Stahl, B, et al. Galacto-oligosaccharides and long-chain fructo-oligosaccharides as prebiotics in infant formulas: a review. Acta Paediatr. (2005) 94:22–6. doi: 10.1111/j.1651-2227.2005.tb02150.x,

PubMed Abstract | Crossref Full Text | Google Scholar

48. Lamsal, BP. Production, health aspects and potential food uses of dairy prebiotic galactooligosaccharides. J Sci Food Agric. (2012) 92:2020–8. doi: 10.1002/jsfa.5712,

PubMed Abstract | Crossref Full Text | Google Scholar

49. Panesar, PS, and Kumari, S. Lactulose: production, purification and potential applications. Biotechnol Adv. (2011) 29:940–8. doi: 10.1016/j.biotechadv.2011.08.008,

PubMed Abstract | Crossref Full Text | Google Scholar

50. Izydorczyk, MS. Arabinoxylans In: Handbook of hydrocolloids GO Phillips and PA Williams, editors. Oxford, UK: Elsevier (2021). 399–461. doi: 10.1016/B978-0-12-820104-6.00016-4

Crossref Full Text | Google Scholar

51. Lin, SH, Chou, LM, Chien, YW, Chang, JS, and Lin, CI. Prebiotic effects of xylooligosaccharides on the improvement of microbiota balance in human subjects. Gastroenterol Res Pract. (2016) 2016:5789232. doi: 10.1155/2016/5789232,

PubMed Abstract | Crossref Full Text | Google Scholar

52. Rini, DM, Xu, W, and Suzuki, T. Current research on the role of isomaltooligosaccharides in gastrointestinal health and metabolic diseases. Prevent Nutr Food Sci. (2024) 29:93–105. doi: 10.3746/pnf.2024.29.2.93,

PubMed Abstract | Crossref Full Text | Google Scholar

53. Lecerf, JM, Dépeint, F, Clerc, E, Dugenet, Y, Niamba, CN, Rhazi, L, et al. Xylo-oligosaccharide (XOS) in combination with inulin modulates both the intestinal environment and immune status in healthy subjects, while XOS alone only shows prebiotic properties. Br J Nutr. (2012) 108:1847–58. doi: 10.1017/S0007114511007252,

PubMed Abstract | Crossref Full Text | Google Scholar

54. Hooge, DM. Meta-analysis of broiler chicken pen trials evaluating dietary mannan oligosaccharide, 1993-2003. Int J Poult Sci. (2004) 3:163–74. doi: 10.3923/ijps.2004.163.174

Crossref Full Text | Google Scholar

55. Hooge, DM, and Connolly, A. Meta-analysis summary of broiler chicken trials with dietary Actigen®(2009–2011). Int J Poult Sci. (2011) 10:819–24. doi: 10.3923/ijps.2013.1.8

Crossref Full Text | Google Scholar

56. Adhikari, PA, and Kim, WK. Overview of prebiotics and probiotics: focus on performance, gut health and immunity-a review. Ann Anim Sci. (2017) 17:949. doi: 10.1515/aoas-2016-0092

Crossref Full Text | Google Scholar

57. Ferket, P., Santos, A., and Oviedo-Rondon, E. (2005). "Dietary factors that affect gut health and pathogen colonization", In: 32nd Annual Carolina Poultry Nutrition Conference Sheraton Imperial Hotel, RTP, NC), North Caroline: The North Carolina Poultry Federation.

Google Scholar

58. Baurhoo, B, Phillip, L, and Ruiz-Feria, C. Effects of purified lignin and mannan oligosaccharides on intestinal integrity and microbial populations in the ceca and litter of broiler chickens. Poult Sci. (2007) 86:1070–8. doi: 10.1093/ps/86.6.1070

Crossref Full Text | Google Scholar

59. Yang, Y, Iji, P, and Choct, M. Effects of different dietary levels of mannanoligosaccharide on growth performance and gut development of broiler chickens. Asian Australas J Anim Sci. (2007) 20:1084–91. doi: 10.5713/ajas.2007.1084

Crossref Full Text | Google Scholar

60. Shanmugasundaram, R, and Selvaraj, R. Effect of killed whole yeast cell prebiotic supplementation on broiler performance and intestinal immune cell parameters. Poult Sci. (2012) 91:107–11. doi: 10.3382/ps.2011-01732,

PubMed Abstract | Crossref Full Text | Google Scholar

61. Kim, GB, Seo, Y, Kim, C, and Paik, I. Effect of dietary prebiotic supplementation on the performance, intestinal microflora, and immune response of broilers. Poult Sci. (2011) 90:75–82. doi: 10.3382/ps.2010-00732,

PubMed Abstract | Crossref Full Text | Google Scholar

62. Calik, A, and Ergün, A. Effect of lactulose supplementation on growth performance, intestinal histomorphology, cecal microbial population, and short-chain fatty acid composition of broiler chickens. Poult Sci. (2015) 94:2173–82. doi: 10.3382/ps/pev182,

PubMed Abstract | Crossref Full Text | Google Scholar

63. Cho, J, and Kim, I. Effects of lactulose supplementation on performance, blood profiles, excreta microbial shedding of Lactobacillus and Escherichia coli, relative organ weight and excreta noxious gas contents in broilers. J Anim Physiol Anim Nutr. (2014) 98:424–30. doi: 10.1111/jpn.12086,

PubMed Abstract | Crossref Full Text | Google Scholar

64. Ricke, S. Potential of fructooligosaccharide prebiotics in alternative and nonconventional poultry production systems. Poult Sci. (2015) 94:1411–8. doi: 10.3382/ps/pev049,

PubMed Abstract | Crossref Full Text | Google Scholar

65. Alloui, MN, Szczurek, W, and Swiatkiewicz, S. The usefulness of prebiotics and probiotics in modern poultry nutrition: a review. Ann Anim Sci. (2013) 13:17. doi: 10.2478/v10220-012-0055-x

Crossref Full Text | Google Scholar

66. Awad, W, Ghareeb, K, Abdel-Raheem, S, and Böhm, J. Effects of dietary inclusion of probiotic and synbiotic on growth performance, organ weights, and intestinal histomorphology of broiler chickens. Poult Sci. (2009) 88:49–56. doi: 10.3382/ps.2008-00244,

PubMed Abstract | Crossref Full Text | Google Scholar

67. Boostani, A, Mahmoodian Fard, HR, Ashayerizadeh, A, and Aminafshar, M. Growth performance, carcass yield and intestinal microflora populations of broilers fed diets containing Thepax and yogurt. Braz J Poult Sci. (2013) 15:1. doi: 10.1590/S1516-635X2013000100001

Crossref Full Text | Google Scholar

68. Mohnl, M, Acosta Aragon, Y, Acosta Ojeda, A, Rodriguez Sanchez, B, and Pasteiner, S. Effect of synbiotic feed additive in comparison to antibiotic growth promoter on performance and health status of broilers. J Dairy Sci. (2007) 90:217–7.

Google Scholar

69. Yitbarek, A, Echeverry, H, Munyaka, P, and Rodriguez-Lecompte, J. Innate immune response of pullets fed diets supplemented with prebiotics and synbiotics. Poult Sci. (2015) 94:1802–11. doi: 10.3382/ps/pev147,

PubMed Abstract | Crossref Full Text | Google Scholar

70. Jung, SJ, Houde, R, Baurhoo, B, Zhao, X, and Lee, BH. Effects of galacto-oligosaccharides and a Bifidobacteria lactis-based probiotic strain on the growth performance and fecal microflora of broiler chickens. Poult Sci. (2008) 87:1694–9. doi: 10.3382/ps.2007-00489,

PubMed Abstract | Crossref Full Text | Google Scholar

71. Sohail, M, Hume, M, Byrd, J, Nisbet, D, Ijaz, A, Sohail, A, et al. Effect of supplementation of prebiotic mannan-oligosaccharides and probiotic mixture on growth performance of broilers subjected to chronic heat stress. Poult Sci. (2012) 91:2235–40. doi: 10.3382/ps.2012-02182,

PubMed Abstract | Crossref Full Text | Google Scholar

72. Dibner, J, and Buttin, P. Use of organic acids as a model to study the impact of gut microflora on nutrition and metabolism. J Appl Poult Res. (2002) 11:453–63. doi: 10.1093/japr/11.4.453

Crossref Full Text | Google Scholar

73. Ali, Q, Ma, S, La, S, Guo, Z, Liu, B, Gao, Z, et al. Microbial short-chain fatty acids: a bridge between dietary fibers and poultry gut health—a review. Anim Biosci. (2022) 35:1461–78. doi: 10.5713/ab.21.0562,

PubMed Abstract | Crossref Full Text | Google Scholar

74. Banday, M, Adil, S, Khan, A, and Untoo, M. A study on efficacy of fumaric acid supplementation in diet of broiler chicken. Int J Poult Sci. (2015) 14:589–94. doi: 10.3923/ijps.2015.589.594

Crossref Full Text | Google Scholar

75. Adil, S, Banday, T, Ahmad, BG, Salahuddin, M, Raquib, M, and Shanaz, S. Response of broiler chicken to dietary supplementation of organic acids. J Cent Eur Agric. (2011) 12:947. doi: 10.5513/JCEA01/12.3.947

Crossref Full Text | Google Scholar

76. Salgado-Tránsito, L, Del Río-García, J, Arjona-Román, J, Moreno-Martínez, E, and Méndez-Albores, A. Effect of citric acid supplemented diets on aflatoxin degradation, growth performance and serum parameters in broiler chickens. Arch Med Vet. (2011) 43:215–22. doi: 10.4067/S0301-732X2011000300003

Crossref Full Text | Google Scholar

77. Panda, A, Rama Rao, S, Raju, M, and Shyam Sunder, G. Effect of butyric acid on performance, gastrointestinal tract health and carcass characteristics in broiler chickens. Asian Australas J Anim Sci. (2009) 22:1026–31. doi: 10.5713/ajas.2009.80298

Crossref Full Text | Google Scholar

78. Kövilein, A, Kubisch, C, Cai, L, and Ochsenreither, K. Malic acid production from renewables: a review. J Chem Technol Biotechnol. (2020) 95:513–26. doi: 10.1002/jctb.6269

Crossref Full Text | Google Scholar

79. Steels, H, James, S, Roberts, I, and Stratford, M. Sorbic acid resistance: the inoculum effect. Yeast. (2000) 16:1173–83. doi: 10.1002/1097-0061(20000930)16:13<1173::AID-YEA617>3.0.CO;2-8,

PubMed Abstract | Crossref Full Text | Google Scholar

80. Gal, J. The discovery of biological enantioselectivity: Louis Pasteur and the fermentation of tartaric acid, 1857—a review and analysis 150 yr later. Chirality. (2008) 20:5–19. doi: 10.1002/chir.20494,

PubMed Abstract | Crossref Full Text | Google Scholar

81. Samanta, S, Haldar, S, and Ghosh, T. Production and carcase traits in broiler chickens given diets supplemented with inorganic trivalent chromium and an organic acid blend. Br Poult Sci. (2008) 49:155–63. doi: 10.1080/00071660801946950,

PubMed Abstract | Crossref Full Text | Google Scholar

82. Vahjen, W, Mader, A, Knorr, F, Ruhnke, I, Röhe, I, Hafeez, A, et al. The effects of different thermal treatments and organic acid levels in feed on microbial composition and activity in gastrointestinal tract of broilers. Poult Sci. (2014) 93:1440–52. doi: 10.3382/ps.2013-03763

Crossref Full Text | Google Scholar

83. Hoseinifar, SH, Dadar, M, and Ringø, E. Modulation of nutrient digestibility and digestive enzyme activities in aquatic animals: the functional feed additives scenario. Aquac Res. (2017) 48:3987–4000. doi: 10.1111/are.13368

Crossref Full Text | Google Scholar

84. Kim, JW, Kim, JH, and Kil, DY. Dietary organic acids for broiler chickens: a review. Rev Colomb Cienc Pecu. (2015) 28:109–23. doi: 10.17533/udea.rccp.v28n2a01

Crossref Full Text | Google Scholar

85. Li, M, Yu, Q, Xu, J, Sun, H, Cheng, Q, Xie, Y, et al. Effect of different organic acid additives on the fermentation quality and bacterial community of paper mulberry (Broussonetia papyrifera) silage. Front Microbiol. (2022) 13:8549. doi: 10.3389/fmicb.2022.1038549,

PubMed Abstract | Crossref Full Text | Google Scholar

86. Nguyen, DH, Seok, WJ, and Kim, IH. Organic acids mixture as a dietary additive for pigs—a review. Animals. (2020) 10:952. doi: 10.3390/ani10060952,

PubMed Abstract | Crossref Full Text | Google Scholar

87. Thacker, PA. Alternatives to antibiotics as growth promoters for use in swine production: a review. J Anim Sci Biotechnol. (2013) 4:1–12. doi: 10.1186/2049-1891-4-35

Crossref Full Text | Google Scholar

88. Woyengo, TA, and Nyachoti, CM. Review: Supplementation of phytase and carbohydrases to diets for poultry. Canadian J Anim Sci. (2011) 91:177–92. doi: 10.4141/cjas10081

Crossref Full Text | Google Scholar

89. Hooge, D, Pierce, J, McBride, K, and Rigolin, P. Meta-analysis of broiler chicken trials using diets with or without Allzyme® SSF enzyme complex. Int J Poult Sci. (2010) 9:819–23. doi: 10.3923/ijps.2010.819.823

Crossref Full Text | Google Scholar

90. Jackson, M, and Hanford, K. Statistical meta-analysis of pen trials conducted testing heat-sensitive β-mannanase (hemicell) feed enzyme in male broilers grown to market age. Poult Sci. (2014) 93:66

Google Scholar

91. Swann, D, and Romero, L. A meta-analysis on effect of a multienzyme solution on apparent ileal undigested starch, fat and crude protein in broilers. Poult Sci. (2014) 93:2501–13. doi: 10.3382/ps.2013-03789,

PubMed Abstract | Crossref Full Text | Google Scholar

92. Kiarie, E, Romero, LF, and Nyachoti, CM. The role of added feed enzymes in promoting gut health in swine and poultry. Nutr Res Rev. (2013) 26:71–88. doi: 10.1017/S0954422413000048,

PubMed Abstract | Crossref Full Text | Google Scholar

93. Windisch, W, Schedle, K, Plitzner, C, and Kroismayr, A. Use of phytogenic products as feed additives for swine and poultry. J Anim Sci. (2008) 86:E140–8. doi: 10.2527/jas.2007-0459,

PubMed Abstract | Crossref Full Text | Google Scholar

94. Biswas, S, and Kim, IH. A thorough review of phytogenic feed additives in non-ruminant nutrition: production, gut health, and environmental concerns. J Anim Sci Technol. (2025) 67:497–519. doi: 10.5187/jast.2025.e26,

PubMed Abstract | Crossref Full Text | Google Scholar

95. Liu, Y, Zhang, J, Wang, S, Guo, Y, He, T, and Zhou, R. A novel adjuvant "Sublancin" enhances immune response in specific pathogen-free broiler chickens inoculated with Newcastle disease vaccine. J Immunol Res. (2019) 2019:1016567. doi: 10.1155/2019/1016567,

PubMed Abstract | Crossref Full Text | Google Scholar

96. Settle, T, Leonard, SS, Falkenstei, E, Fix, N, and Klandorf, H. Effects of a phytogenic feed additive versus an antibiotic feed additive on oxidative stress in broiler chicks and a possible mechanism determined by electron spin resonance. Int J Poult Sci. (2014) 13:62–9. doi: 10.3923/ijps.2014.62.69

Crossref Full Text | Google Scholar

97. Pourhossein, Z, Qotbi, AA, Seidavi, A, Laudadio, V, Centoducati, G, and Tufarelli, V. Effect of different levels of dietary sweet orange (Citrus sinensis) peel extract on humoral immune system responses in broiler chickens. Anim Sci J. (2015) 86:105–10. doi: 10.1111/asj.12250,

PubMed Abstract | Crossref Full Text | Google Scholar

98. Hashemipour, H, Kermanshahi, H, Golian, A, and Khaksar, V. Effects of carboxy methyl cellulose and thymol + carvacrol on performance, digesta viscosity and some blood metabolites of broilers. J Anim Physiol Anim Nutr. (2014) 98:672–9. doi: 10.1111/jpn.12121,

PubMed Abstract | Crossref Full Text | Google Scholar

99. Heo, JM, Opapeju, FO, Pluske, JR, Kim, JC, Hampson, DJ, and Nyachoti, CM. Gastrointestinal health and function in weaned pigs: a review of feeding strategies to control post-weaning diarrhoea without using in-feed antimicrobial compounds. J Anim Physiol Anim Nutr. (2013) 97:207–37. doi: 10.1111/j.1439-0396.2012.01284.x

Crossref Full Text | Google Scholar

100. Murugesan, GR, Syed, B, Haldar, S, and Pender, C. Phytogenic feed additives as an alternative to antibiotic growth promoters in broiler chickens. Front Vet Sci. (2015) 2:21. doi: 10.3389/fvets.2015.00021,

PubMed Abstract | Crossref Full Text | Google Scholar

101. Placha, I, Takacova, J, Ryzner, M, Cobanova, K, Laukova, A, Strompfova, V, et al. Effect of thyme essential oil and selenium on intestine integrity and antioxidant status of broilers. Brazilian J Poultry Sci. (2014) 55:105–14. doi: 10.1080/00071668.2013.873772,

PubMed Abstract | Crossref Full Text | Google Scholar

102. Van Der Klis, J., and Vinyeta-Punti, E. (2014). "The potential of phytogenic feed additives in pigs and poultry", In: Proceedings of 18th Congress of the European Society of Veterinary and Comparative Nutrition, At Utrecht, Netherlands), Utrecht.

Google Scholar

103. Applegate, TJ, Klose, V, Steiner, T, Ganner, A, and Schatzmayr, G. Probiotics and phytogenics for poultry: myth or reality? J Appl Poult Res. (2010) 19:194–210. doi: 10.3382/japr.2010-00168

Crossref Full Text | Google Scholar

104. Guo, FC, Kwakkel, RP, Soede, J, Williams, BA, and Verstegen, MW. Effect of a Chinese herb medicine formulation, as an alternative for antibiotics, on performance of broilers. Br Poult Sci. (2004) 45:793–7. doi: 10.1080/00071660400012741,

PubMed Abstract | Crossref Full Text | Google Scholar

105. Cao, FL, Zhang, XH, Yu, WW, Zhao, LG, and Wang, T. Effect of feeding fermented Ginkgo biloba leaves on growth performance, meat quality, and lipid metabolism in broilers. Poult Sci. (2012) 91:1210–21. doi: 10.3382/ps.2011-01886,

PubMed Abstract | Crossref Full Text | Google Scholar

106. Zhao, XH, He, X, Yang, XF, and Zhong, XH. Effect of Portulaca oleracea extracts on growth performance and microbial populations in ceca of broilers. Poult Sci. (2013) 92:1343–7. doi: 10.3382/ps.2012-02434,

PubMed Abstract | Crossref Full Text | Google Scholar

107. Chamorro, S, Viveros, A, Centeno, C, Romero, C, Arija, I, and Brenes, A. Effects of dietary grape seed extract on growth performance, amino acid digestibility and plasma lipids and mineral content in broiler chicks. Animal. (2013) 7:555–61. doi: 10.1017/s1751731112001851,

PubMed Abstract | Crossref Full Text | Google Scholar

108. Amerah, AM, Péron, A, Zaefarian, F, and Ravindran, V. Influence of whole wheat inclusion and a blend of essential oils on the performance, nutrient utilisation, digestive tract development and ileal microbiota profile of broiler chickens. Br Poult Sci. (2011) 52:124–32. doi: 10.1080/00071668.2010.548791,

PubMed Abstract | Crossref Full Text | Google Scholar

109. Hashemipour, H, Kermanshahi, H, Golian, A, and Veldkamp, T. Effect of thymol and carvacrol feed supplementation on performance, antioxidant enzyme activities, fatty acid composition, digestive enzyme activities, and immune response in broiler chickens. Poult Sci. (2013) 92:2059–69. doi: 10.3382/ps.2012-02685,

PubMed Abstract | Crossref Full Text | Google Scholar

110. Kim, SJ, Lee, KW, Kang, CW, and An, BK. Growth performance, relative meat and organ weights, cecal microflora, and blood characteristics in broiler chickens fed diets containing different nutrient density with or without essential oils. Asian Australas J Anim Sci. (2016) 29:549–54. doi: 10.5713/ajas.15.0426,

PubMed Abstract | Crossref Full Text | Google Scholar

111. Bravo, D, and Ionescu, C. Meta-analysis of the effect of a mixture of carvacrol, cinnamaldehyde and capsicum oleoresin in broilers. Poultry Sci. (2008) 87:75–5. doi: 10.3920/9789086865789_300

Crossref Full Text | Google Scholar

112. Pirgozliev, V, Bravo, D, Mirza, MW, and Rose, SP. Growth performance and endogenous losses of broilers fed wheat-based diets with and without essential oils and xylanase supplementation. Poult Sci. (2015) 94:1227–32. doi: 10.3382/ps/peu017,

PubMed Abstract | Crossref Full Text | Google Scholar

113. Facchi, CS, Valentini, FDA, Pagnussatt, H, Leite, F, Santo, AD, Aniecevski, E, et al. Effects of microencapsulated carvacrol and cinnamaldehyde on feed digestibility, intestinal mucosa, and biochemical and antioxidant parameters in broilers. Rev Bras Zootec. (2023) 52:e20220079. doi: 10.37496/rbz5220220079

Crossref Full Text | Google Scholar

114. Wang, Y, Wang, Y, Su, C, Wang, L, Lv, X, Cui, G, et al. Dietary cinnamaldehyde with carvacrol or thymol improves the egg quality and intestinal health independent of gut microbiota in post-peak laying hens. Front Vet Sci. (2022) 9:994089. doi: 10.3389/fvets.2022.994089,

PubMed Abstract | Crossref Full Text | Google Scholar

115. Su, W, Gong, T, Jiang, Z, Lu, Z, and Wang, Y. The role of probiotics in alleviating postweaning diarrhea in piglets from the perspective of intestinal barriers. Front Cell Infect Microbiol. (2022) 12:3107. doi: 10.3389/fcimb.2022.883107,

PubMed Abstract | Crossref Full Text | Google Scholar

116. Gadde, U, Rathinam, T, and Lillehoj, HS. Passive immunization with hyperimmune egg-yolk IgY as prophylaxis and therapy for poultry diseases--a review. Anim Health Res Rev. (2015) 16:163–76. doi: 10.1017/s1466252315000195,

PubMed Abstract | Crossref Full Text | Google Scholar

117. Cook, ME. Antibodies: alternatives to antibiotics in improving growth and feed efficiency. J Appl Poult Res. (2004) 13:106–19. doi: 10.1093/japr/13.1.106

Crossref Full Text | Google Scholar

118. Pimentel, JL, Cook, ME, and Jonsson, JM. Research note: increased growth of chicks and poults obtained from hens injected with jackbean urease. Poult Sci. (1991) 70:1842–4. doi: 10.3382/ps.0701842,

PubMed Abstract | Crossref Full Text | Google Scholar

119. Lee, SH, Lillehoj, HS, Park, DW, Jang, SI, Morales, A, García, D, et al. Induction of passive immunity in broiler chickens against Eimeria acervulina by hyperimmune egg yolk immunoglobulin Y. Poult Sci. (2009) 88:562–6. doi: 10.3382/ps.2008-00340,

PubMed Abstract | Crossref Full Text | Google Scholar

120. Klasing, KC, Laurin, DE, Peng, RK, and Fry, DM. Immunologically mediated growth depression in chicks: influence of feed intake, corticosterone and interleukin-1. J Nutr. (1987) 117:1629–37. doi: 10.1093/jn/117.9.1629,

PubMed Abstract | Crossref Full Text | Google Scholar

121. Di, C, Manzar, A, Fatima,, Yunxia, L, Gaoping, Z, Ghulam, A, et al. Base editing: a promising tool for genetic manipulation in mammalian somatic and stem cell lines. Pak J Sci. (2025) 76:553–69. doi: 10.57041/vol76iss04pp553-569

Crossref Full Text | Google Scholar

122. Dou, D, Shen, L, Zhou, J, Cao, Z, Luan, P, Li, Y, et al. Genome-wide association studies for growth traits in broilers. BMC Genomic Data. (2022) 23:1. doi: 10.1186/s12863-021-01017-7,

PubMed Abstract | Crossref Full Text | Google Scholar

123. Ren, J, Gao, Z, Lu, Y, Li, M, Hong, J, Wu, J, et al. Application of GWAS and mGWAS in livestock and poultry breeding. Animals. (2024) 14:2382. doi: 10.3390/ani14162382,

PubMed Abstract | Crossref Full Text | Google Scholar

124. Nesbitt, C, Galina Pantoja, L, Beaton, B, Chen, CY, Culbertson, M, Harms, P, et al. Pigs lacking the SRCR5 domain of CD163 protein demonstrate heritable resistance to the PRRS virus and no changes in animal performance from birth to maturity. Front Genome Editing. (2024) 6:1322012. doi: 10.3389/fgeed.2024.1322012,

PubMed Abstract | Crossref Full Text | Google Scholar

125. Whitworth, KM, and Prather, RS. Gene editing as applied to prevention of reproductive porcine reproductive and respiratory syndrome. Mol Reprod Dev. (2017) 84:926–33. doi: 10.1002/mrd.22811,

PubMed Abstract | Crossref Full Text | Google Scholar

126. la De Fuente, J, Fernández, AM, Alberdi, P, Sánchez, SD, Álvarez, OG, Melgar, RF, et al. A quantum vaccinomics approach for the design and production of MSP4 chimeric antigen for the control of Anaplasma phagocytophilum infections. Vaccines (Basel). (2022) 10:1995. doi: 10.3390/vaccines10121995

Crossref Full Text | Google Scholar

127. Hasan, M, Ahmed, S, Imranuzzaman, M, Bari, R, Roy, S, Hasan, MM, et al. Designing and development of efficient multi-epitope-based peptide vaccine candidate against emerging avian rotavirus strains: a vaccinomic approach. J Genet Eng Biotechnol. (2024) 22:100398. doi: 10.1016/j.jgeb.2024.100398,

PubMed Abstract | Crossref Full Text | Google Scholar

128. Wang, K, Yan, J, Dang, W, Xie, J, Yan, B, Yan, W, et al. Dual antifungal properties of cationic antimicrobial peptides polybia-MPI: membrane integrity disruption and inhibition of biofilm formation. Peptides. (2014) 56:22–9. doi: 10.1016/j.peptides.2014.03.005,

PubMed Abstract | Crossref Full Text | Google Scholar

129. Fosgerau, K, and Hoffmann, T. Peptide therapeutics: current status and future directions. Drug Discov Today. (2015) 20:122–8. doi: 10.1016/j.drudis.2014.10.003,

PubMed Abstract | Crossref Full Text | Google Scholar

130. Wen, LF, and He, JG. Dose-response effects of an antimicrobial peptide, a cecropin hybrid, on growth performance, nutrient utilisation, bacterial counts in the digesta and intestinal morphology in broilers. Br J Nutr. (2012) 108:1756–63. doi: 10.1017/s0007114511007240,

PubMed Abstract | Crossref Full Text | Google Scholar

131. Choi, SC, Ingale, SL, Kim, JS, Park, YK, Kwon, IK, and Chae, BJ. An antimicrobial peptide-A3: effects on growth performance, nutrient retention, intestinal and faecal microflora and intestinal morphology of broilers. Br Poult Sci. (2013) 54:738–46. doi: 10.1080/00071668.2013.838746,

PubMed Abstract | Crossref Full Text | Google Scholar

132. Wang, D, Ma, W, She, R, Sun, Q, Liu, Y, Hu, Y, et al. Effects of swine gut antimicrobial peptides on the intestinal mucosal immunity in specific-pathogen-free chickens. Poult Sci. (2009) 88:967–74. doi: 10.3382/ps.2008-00533,

PubMed Abstract | Crossref Full Text | Google Scholar

133. Willey, JM, and van der Donk, WA. Lantibiotics: peptides of diverse structure and function. Ann Rev Microbiol. (2007) 61:477–501. doi: 10.1146/annurev.micro.61.080706.093501,

PubMed Abstract | Crossref Full Text | Google Scholar

134. Engberg, RM, Hedemann, MS, and Jensen, BB. The influence of grinding and pelleting of feed on the microbial composition and activity in the digestive tract of broiler chickens. Brazilian J Poultry Sci. (2002) 43:569–79. doi: 10.1080/0007166022000004480,

PubMed Abstract | Crossref Full Text | Google Scholar

135. Józefiak, D, Kierończyk, B, Juśkiewicz, J, Zduńczyk, Z, Rawski, M, Długosz, J, et al. Dietary nisin modulates the gastrointestinal microbial ecology and enhances growth performance of the broiler chickens. PLoS One. (2013) 8:e85347. doi: 10.1371/journal.pone.0085347,

PubMed Abstract | Crossref Full Text | Google Scholar

136. Wang, HT, Li, YH, Chou, IP, Hsieh, YH, Chen, BJ, and Chen, CY. Albusin B modulates lipid metabolism and increases antioxidant defense in broiler chickens by a proteomic approach. J Sci Food Agric. (2013) 93:284–92. doi: 10.1002/jsfa.5754,

PubMed Abstract | Crossref Full Text | Google Scholar

137. Wang, HT, Yu, C, Hsieh, YH, Chen, SW, Chen, BJ, and Chen, CY. Effects of albusin B (a bacteriocin) of Ruminococcus albus 7 expressed by yeast on growth performance and intestinal absorption of broiler chickens--its potential role as an alternative to feed antibiotics. J Sci Food Agric. (2011) 91:2338–43. doi: 10.1002/jsfa.4463,

PubMed Abstract | Crossref Full Text | Google Scholar

138. Miller, RW, Skinner, EJ, Sulakvelidze, A, Mathis, GF, and Hofacre, CL. Bacteriophage therapy for control of necrotic enteritis of broiler chickens experimentally infected with Clostridium perfringens. Avian Dis. (2010) 54:33–40. doi: 10.1637/8953-060509-Reg.1,

PubMed Abstract | Crossref Full Text | Google Scholar

139. Huff, WE, Huff, GR, Rath, NC, Balog, JM, and Donoghue, AM. Bacteriophage: potential role in food safety In: RC Beier, SD Pillai, and TD Phillips, editors. Preharvest and postharvest food safety. (Hoboken: Wiley-Blackwell Publishing) (2008)

Google Scholar

140. Zhao, PY, Baek, HY, and Kim, IH. Effects of bacteriophage supplementation on egg performance, egg quality, excreta microflora, and moisture content in laying hens. Asian Australas J Anim Sci. (2012) 25:1015–20. doi: 10.5713/ajas.2012.12026,

PubMed Abstract | Crossref Full Text | Google Scholar

141. Kim, S, Kim, J, Kim, J, and Kim, I. Effects of dietary supplementation of bacteriophage CP on growth performance, nutrient digestibility, blood profiles, carcass characteristics and fecal microflora in broilers. Korean J Poult Sci. (2013) 40:75. doi: 10.5536/KJPS.2013.40.1.075

Crossref Full Text | Google Scholar

142. Wang, JP, Yan, L, Lee, JH, and Kim, IH. Evaluation of bacteriophage supplementation on growth performance, blood characteristics, relative organ weight, breast muscle characteristics and excreta microbial shedding in broilers. Asian Australas J Anim Sci. (2013) 26:573–8. doi: 10.5713/ajas.2012.12544,

PubMed Abstract | Crossref Full Text | Google Scholar

143. Vondruskova, H, Slamova, R, Trckova, M, Zraly, Z, and Pavlik, I. Alternatives to antibiotic growth promoters in prevention of diarrhoea in weaned piglets: a review. Vet Med (Praha). (2010) 55:199–224. doi: 10.17221/2998-VETMED

Crossref Full Text | Google Scholar

144. Fowler, J, Li, W, and Bailey, C. Effects of a calcium bentonite clay in diets containing aflatoxin when measuring liver residues of aflatoxin B₁ in starter broiler chicks. Toxins (Basel). (2015) 7:3455–64. doi: 10.3390/toxins7093455,

PubMed Abstract | Crossref Full Text | Google Scholar

145. Xia, MS, Hu, CH, and Xu, ZR. Effects of copper-bearing montmorillonite on growth performance, digestive enzyme activities, and intestinal microflora and morphology of male broilers. Poult Sci. (2004) 83:1868–75. doi: 10.1093/ps/83.11.1868,

PubMed Abstract | Crossref Full Text | Google Scholar

146. Prvulovic, D, Kojić, D, Grubor-Lajsic, G, and Kosarcic, S. The effects of dietary inclusion of hydrated aluminosilicate on performance and biochemical parameters of broiler chickens. Turk J Vet Anim Sci. (2008) 32:159–66.

Google Scholar

147. Lemos, MJD, Calixto, LFL, Alves, ODS, Souza, DSD, Moura, BB, and Reis, TL. Kaolin in the diet and its effects on performance, litter moisture and intestinal morphology of broiler chickens. Cienc Rural. (2015) 45:1835–40. doi: 10.1590/0103-8478cr20141193

Crossref Full Text | Google Scholar

148. Wu, Y, Wu, Q, Zhou, Y, Ahmad, H, and Wang, T. Effects of clinoptilolite on growth performance and antioxidant status in broilers. Biol Trace Elem Res. (2013) 155:228–35. doi: 10.1007/s12011-013-9777-6,

PubMed Abstract | Crossref Full Text | Google Scholar

149. Attia, YA, Qota, EM, Zeweil, HS, Bovera, F, Abd Al-Hamid, AE, and Sahledom, MD. Effect of different dietary concentrations of inorganic and organic copper on growth performance and lipid metabolism of white Pekin male ducks. Br Poult Sci. (2012) 53:77–88. doi: 10.1080/00071668.2011.650151,

PubMed Abstract | Crossref Full Text | Google Scholar

150. Vasanth, D, Mercy, MT, and Dshyama, A. Efficiency of copper Sulphate versus Flavomycin as a growth promoter in broiler chickens. Int J Curr Res. (2015) 7:16536–9.

Google Scholar

151. Payvastegan, S, Farhoomand, P, and Delfani, N. Growth performance, organ weights and, blood parameters of broilers fed diets containing graded levels of dietary canola meal and supplemental copper. J Poult Sci. (2013) 50:354–63. doi: 10.2141/jpsa.0130006

Crossref Full Text | Google Scholar

152. Chowdhury, S, Paik, I, Namkung, H, and Lim, H. Responses of broiler chickens to organic copper fed in the form of copper–methionine chelate. Anim Feed Sci Technol. (2004) 115:281–93. doi: 10.1016/j.anifeedsci.2004.03.009

Crossref Full Text | Google Scholar

153. Lu, L, Wang, RL, Zhang, ZJ, Steward, FA, Luo, X, and Liu, B. Effect of dietary supplementation with copper sulfate or tribasic copper chloride on the growth performance, liver copper concentrations of broilers fed in floor pens, and stabilities of vitamin E and phytase in feeds. Biol Trace Elem Res. (2010) 138:181–9. doi: 10.1007/s12011-010-8623-3,

PubMed Abstract | Crossref Full Text | Google Scholar

154. Richards, JD, Zhao, J, Harrell, RJ, Atwell, CA, and Dibner, JJ. Trace mineral nutrition in poultry and swine. Asian Australas J Anim Sci. (2010) 23:1527–34. doi: 10.5713/ajas.2010.r.07

Crossref Full Text | Google Scholar

155. Burrell, AL, Dozier, WA 3rd, Davis, AJ, Compton, MM, Freeman, ME, Vendrell, PF, et al. Responses of broilers to dietary zinc concentrations and sources in relation to environmental implications. Brazilian J Poultry Sci. (2004) 45:225–63. doi: 10.1080/00071660410001715867,

PubMed Abstract | Crossref Full Text | Google Scholar

156. Yogesh, K, Deo, C, Shrivastava, HP, Mandal, AB, Wadhwa, A, and Singh, I. Growth performance, carcass yield, and immune competence of broiler chickens as influenced by dietary supplemental zinc sources and levels. Agric Res. (2013) 2:270–4. doi: 10.1007/s40003-013-0067-5

Crossref Full Text | Google Scholar

157. Yazdankhah, S, Rudi, K, and Bernhoft, A. Zinc and copper in animal feed - development of resistance and co-resistance to antimicrobial agents in bacteria of animal origin. Microb Ecol Health Dis. (2014) 25:5862. doi: 10.3402/mehd.v25.25862,

PubMed Abstract | Crossref Full Text | Google Scholar

158. Ng’ang’a, ZW, Tous, N, Ballester, M, Leskovec, J, Jimenez-Moya, B, Beltrán-Debón, R, et al. Impact of zinc oxide on gut health, immunity, and growth in weaned piglets: exploring potential modes of action. Front Vet Sci. (2025) 12:5900. doi: 10.3389/fvets.2025.1645900,

PubMed Abstract | Crossref Full Text | Google Scholar

159. Ekhlas, D, Sanjuán, JMO, Manzanilla, EG, Leonard, FC, Argüello, H, and Burgess, CM. Comparison of antimicrobial resistant Escherichia coli isolated from Irish commercial pig farms with and without zinc oxide and antimicrobial usage. Gut Pathogens. (2023) 15:8. doi: 10.1186/s13099-023-00534-3,

PubMed Abstract | Crossref Full Text | Google Scholar

160. Shurson, GC, Urriola, PE, and Hung, YT. Too much of a good thing: rethinking feed formulation and feeding practices for zinc in swine diets to achieve one health and environmental sustainability. Animals (Basel). (2022) 12:3374. doi: 10.3390/ani12233374,

PubMed Abstract | Crossref Full Text | Google Scholar

161. Abbas, G, Khan, SH, and Rehman, HU. Effects of formic acid administration in the drinking water on production performance, egg quality and immune system in layers during hot season. Avian Biol Res. (2013) 6:227–32. doi: 10.3184/175815513x13740707043279

Crossref Full Text | Google Scholar

162. Koyuncu, S, Andersson, MG, Löfström, C, Skandamis, PN, Gounadaki, A, Zentek, J, et al. Organic acids for control of Salmonella in different feed materials. BMC Vet Res. (2013) 9:81. doi: 10.1186/1746-6148-9-81,

PubMed Abstract | Crossref Full Text | Google Scholar

163. Gonzalez, FE, Martinez, LA, and Perez, AI. Combined effect of organic acids and modified atmosphere packaging on Listeria monocytogenes in chicken legs. Animals (Basel). (2020) 10:1818. doi: 10.3390/ani10101818

Crossref Full Text | Google Scholar

164. Adil, S, Banday, T, Bhat, GA, Mir, MS, and Rehman, M. Effect of dietary supplementation of organic acids on performance, intestinal histomorphology, and serum biochemistry of broiler chicken. Vet Med Int. (2010) 2010:479485. doi: 10.4061/2010/479485,

PubMed Abstract | Crossref Full Text | Google Scholar

165. Makofane, V, Ng'ambi, J, and Gunya, B. The effect of citric acid supplementation on growth performance, digestibility and linear body measurement of Ross 308 broiler chickens: a review. Indian J Anim Res. (2022). 56:387–391. doi: 10.18805/IJAR.BF-1433

Crossref Full Text | Google Scholar

166. Zhang, WH, Jiang, Y, Zhu, QF, Gao, F, Dai, SF, Chen, J, et al. Sodium butyrate maintains growth performance by regulating the immune response in broiler chickens. Br Poult Sci. (2011) 52:292–301. doi: 10.1080/00071668.2011.578121,

PubMed Abstract | Crossref Full Text | Google Scholar

167. Sultan, A, Ullah, T, Khan, S, and Khan, RU. Effect of organic acid supplementation on the performance and ileal microflora of broiler during finishing period. Pak J Zool. (2015) 47:635–9.

Google Scholar

168. Adhikari, P, Yadav, S, Cosby, DE, Cox, NA, Jendza, JA, and Kim, WK. Research note: effect of organic acid mixture on growth performance and Salmonella typhimurium colonization in broiler chickens. Poult Sci. (2020) 99:2645–9. doi: 10.1016/j.psj.2019.12.037,

PubMed Abstract | Crossref Full Text | Google Scholar

169. Mortada, M, Cosby, DE, Akerele, G, Ramadan, N, Oxford, J, Shanmugasundaram, R, et al. Characterizing the immune response of chickens to Campylobacter jejuni (strain A74C). PLoS One. (2021) 16:e0247080. doi: 10.1371/journal.pone.0247080,

PubMed Abstract | Crossref Full Text | Google Scholar

170. Emami, NK, Daneshmand, A, Naeini, SZ, Graystone, EN, and Broom, LJ. Effects of commercial organic acid blends on male broilers challenged with E. coli K88: performance, microbiology, intestinal morphology, and immune response. Poult Sci. (2017) 96:3254–63. doi: 10.3382/ps/pex106,

PubMed Abstract | Crossref Full Text | Google Scholar

171. Kumar, A, Toghyani, M, Kheravii, SK, Pineda, L, Han, Y, Swick, RA, et al. Organic acid blends improve intestinal integrity, modulate short-chain fatty acids profiles and alter microbiota of broilers under necrotic enteritis challenge. Anim Nutr. (2022) 8:82–90. doi: 10.1016/j.aninu.2021.04.003,

PubMed Abstract | Crossref Full Text | Google Scholar

172. Grecco, H, Amorim, A, Saleh, M, Tse, M, Garcia Telles, F, Mello Miassi, G, et al. Evaluation of growth performance and gastro-intestinal parameters on the response of weaned piglets to dietary organic acids. An Acad Bras Cienc. (2018) 90:401–14. doi: 10.1590/0001-3765201820160057

Crossref Full Text | Google Scholar

173. Hanczakowska, E, Szewczyk, A, and Okon, K. Caprylic, capric and/or fumaric acids as antibiotic replacements in piglet feed. Ann Anim Sci. (2011) 11:115–24.

Google Scholar

174. Zentek, J, Ferrara, F, Pieper, R, Tedin, L, Meyer, W, and Vahjen, W. Effects of dietary combinations of organic acids and medium chain fatty acids on the gastrointestinal microbial ecology and bacterial metabolites in the digestive tract of weaning piglets. J Anim Sci. (2013) 91:3200–10. doi: 10.2527/jas.2012-5673,

PubMed Abstract | Crossref Full Text | Google Scholar

175. Li, M, Long, S, Wang, Q, Zhang, L, Hu, J, Yang, J, et al. Mixed organic acids improve nutrients digestibility, volatile fatty acids composition and intestinal microbiota in growing-finishing pigs fed high-fiber diet. Asian Australas J Anim Sci. (2019) 32:856–64. doi: 10.5713/ajas.18.0517,

PubMed Abstract | Crossref Full Text | Google Scholar

176. Hamed, DM, and Hassan, AMA. Acids supplementation to drinking water and their effects on Japanese quails experimentally challenged with Salmonella enteritidis. Res Zool. (2013) 3:15–22. doi: 10.5923/j.zoology.20130301.03

Crossref Full Text | Google Scholar

177. Yang, CJ, Mao, SY, Long, LM, and Zhu, WY. Effect of disodium fumarate on microbial abundance, ruminal fermentation and methane emission in goats under different forage: concentrate ratios. Animal. (2012) 6:1788–94. doi: 10.1017/s1751731112000857,

PubMed Abstract | Crossref Full Text | Google Scholar

178. Genc, B, Salman, M, Bölükbaş, B, Kaya, I, and Acici, M. The effects of fumaric and malic acids on the in vitro true digestibility of some alternative feedstuffs for ruminants. Ankara Üniv Vet Fak Derg. (2020) 67:185–92. doi: 10.33988/auvfd.623821

Crossref Full Text | Google Scholar

179. Faciola, AP, and Broderick, GA. Effects of feeding lauric acid or coconut oil on ruminal protozoa numbers, fermentation pattern, digestion, omasal nutrient flow, and milk production in dairy cows. J Dairy Sci. (2014) 97:5088–100. doi: 10.3168/jds.2013-7653,

PubMed Abstract | Crossref Full Text | Google Scholar

180. Hristov, AN, Lee, C, Cassidy, T, Long, M, Heyler, K, Corl, B, et al. Effects of lauric and myristic acids on ruminal fermentation, production, and milk fatty acid composition in lactating dairy cows. J Dairy Sci. (2011) 94:382–95. doi: 10.3168/jds.2010-3508,

PubMed Abstract | Crossref Full Text | Google Scholar

181. Grilli, E, Bari, R, Piva, A, Edrington, TS, Pitta, DW, Pinchak, WE, et al. Organic acid blend with pure botanical product treatment reduces Escherichia coli and Salmonella populations in pure culture and in in vitro mixed ruminal microorganism fermentations. Foodborne Pathog Dis. (2015) 12:56–61. doi: 10.1089/fpd.2014.1826,

PubMed Abstract | Crossref Full Text | Google Scholar

182. Mikulska, P, Malinowska, M, Ignacyk, M, Szustowski, P, Nowak, J, Pesta, K, et al. Ashwagandha (Withania somnifera)-current research on the health-promoting activities: a narrative review. Pharmaceutics. (2023) 15:1057. doi: 10.3390/pharmaceutics15041057,

PubMed Abstract | Crossref Full Text | Google Scholar

183. Thawabteh, AM, Ghanem, AW, AbuMadi, S, Thaher, D, Jaghama, W, Karaman, R, et al. Antibacterial activity and antifungal activity of monomeric alkaloids. Toxins. (2024) 16:489. doi: 10.3390/toxins16110489,

PubMed Abstract | Crossref Full Text | Google Scholar

184. Błaszczyk, N, Rosiak, A, and Kałużna-Czaplińska, J. The potential role of cinnamon in human health. Forests. (2021) 12:648. doi: 10.3390/f12050648

Crossref Full Text | Google Scholar

185. Gutiérrez, CV, Gutiérrez, CC, Feregrino, AA, Gutiérrez, AC, Lomas, SC, and Guevara, RG. Capsaicinoids and capsinoids of chilli pepper as feed additives in livestock production: current and future trends. Anim Nutr. (2025) 22:483–501. doi: 10.1016/j.aninu.2025.03.014

Crossref Full Text | Google Scholar

186. Pandey, VK, Srivastava, S, Ashish,, Dash, KK, Singh, R, Dar, AH, et al. Bioactive properties of clove (Syzygium aromaticum) essential oil nanoemulsion: a comprehensive review. Heliyon. (2024) 10:e22437. doi: 10.1016/j.heliyon.2023.e22437

Crossref Full Text | Google Scholar

187. Shala, AY, and Gururani, MA. Phytochemical properties and diverse beneficial roles of Eucalyptus globulus Labill.: a review. Horticulturae. (2021) 7:450. doi: 10.3390/horticulturae7110450

Crossref Full Text | Google Scholar

188. Papoutsis, D, Rocha, SDC, Herfindal, AM, Kjølsrud Bøhn, S, and Carlsen, H. Intestinal effect of faba bean fractions in WD-fed mice treated with low dose of DSS. PLoS One. (2022) 17:e0272288. doi: 10.1371/journal.pone.0272288,

PubMed Abstract | Crossref Full Text | Google Scholar

189. El-Saadony, MT, Saad, AM, Korma, SA, Salem, HM, Abd El-Mageed, TA, Alkafaas, SS, et al. Garlic bioactive substances and their therapeutic applications for improving human health: a comprehensive review. Front Immunol. (2024) 15:1277074. doi: 10.3389/fimmu.2024.1277074,

PubMed Abstract | Crossref Full Text | Google Scholar

190. Wang, L, Huang, Y, Yin, G, Wang, J, Wang, P, Chen, ZY, et al. Antimicrobial activities of Asian ginseng, American ginseng, and notoginseng. Phytother Res. (2020) 34:1226–36. doi: 10.1002/ptr.6605,

PubMed Abstract | Crossref Full Text | Google Scholar

191. Reygaert, WC. Green tea catechins: their use in treating and preventing infectious diseases. Biomed Res Int. (2018) 2018:9105261. doi: 10.1155/2018/9105261,

PubMed Abstract | Crossref Full Text | Google Scholar

192. Filban, F, Ravanbakhsh, M, Poormohammadi, A, Khaghani, S, Sadeghi, NB, Neisi, A, et al. Antimicrobial properties of Peganum harmala L. seeds' smoke in indoors: applications and prospects. Environ Moniter Assessment. (2021) 194:17. doi: 10.1007/s10661-021-09665-z

Crossref Full Text | Google Scholar

193. A’yuni, Q, Mok, K, Nakphaichit, M, Jangchud, K, and Pirak, T. Thai Cannabis sativa leaves as a functional ingredient for quality improvement and lactic acid bacterial growth enhancement in Kombucha. Foods. (2025) 14:942. doi: 10.3390/foods14060942

Crossref Full Text | Google Scholar

194. Al-Maharik, N, Salama, Y, Al-Hajj, N, Jaradat, N, Jobran, NT, Warad, I, et al. Chemical composition, anticancer, antimicrobial activity of Aloysia citriodora Palau essential oils from four different locations in Palestine. BMC Complement Med Ther. (2024) 24:94. doi: 10.1186/s12906-024-04390-9,

PubMed Abstract | Crossref Full Text | Google Scholar

195. Hamad, MN, Mohammed, HJ, and Merdaw, MA. Antibacterial activity of Calendula officinalis flowers in vitro. Ibn AL – Haitham J Pure Appl Sci. (2017) 24:735. doi: 10.30526/24.3.735

Crossref Full Text | Google Scholar

196. Shakuri, F, Eghlima, G, Behboudi, H, and Babashpour-Asl, M. Phytochemical variation, phenolic compounds and antioxidant activity of wild populations of Iranian oak. Sci Rep. (2025) 15:6534. doi: 10.1038/s41598-025-90991-4,

PubMed Abstract | Crossref Full Text | Google Scholar

197. Cecchi, L, Migliorini, M, Giambanelli, E, Canuti, V, Bellumori, M, Mulinacci, N, et al. Exploitation of virgin olive oil by-products (Olea europaea L.): phenolic and volatile compounds transformations phenomena in fresh two-phase olive pomace (‘alperujo’) under different storage conditions. J Sci Food Agric. (2022) 102:2515–25. doi: 10.1002/jsfa.11593,

PubMed Abstract | Crossref Full Text | Google Scholar

198. Khounganian, RM, Alwakeel, A, Albadah, A, Nakshabandi, A, Alharbi, S, and Almslam, AS. The antifungal efficacy of pure garlic, onion, and lemon extracts against Candida albicans. Cureus. (2023) 15:e38637. doi: 10.7759/cureus.38637,

PubMed Abstract | Crossref Full Text | Google Scholar

199. Ogo, O, Hembafan, N, Amokaha, R, Jeremiah, O, and Inalegwu, B. Characterization and antioxidant activity of peel extracts from three varieties of Citrus sinensis. Heliyon. (2024) 10:e28456. doi: 10.1016/j.heliyon.2024.e28456,

PubMed Abstract | Crossref Full Text | Google Scholar

200. Srivastava, R, Jaiswal, N, Kharkwal, H, Dubey, NK, and Srivastava, R. Phytomedical properties of Carica papaya for boosting human immunity against viral infections. Viruses. (2025) 17:271. doi: 10.3390/v17020271,

PubMed Abstract | Crossref Full Text | Google Scholar

201. Kamatou, GPP, Vermaak, I, Viljoen, AM, and Lawrence, BM. Menthol: a simple monoterpene with remarkable biological properties. Phytochemistry. (2013) 96:15–25. doi: 10.1016/j.phytochem.2013.08.005,

PubMed Abstract | Crossref Full Text | Google Scholar

202. Steglińska, A, Sulyok, M, Janas, R, Grzesik, M, Liszkowska, W, Kręgiel, D, et al. Metabolite formation by fungal pathogens of potatoes (Solanum tuberosum L.) in the presence of bioprotective agents. Int J Environ Res Public Health. (2023) 20:5221. doi: 10.3390/ijerph20065221,

PubMed Abstract | Crossref Full Text | Google Scholar

203. Hashemi, SMB, Gholamhosseinpour, A, and Barba, FJ. Rosmarinus officinalis L. essential oils impact on the microbiological and oxidative stability of Sarshir (Kaymak). Molecules. (2023) 28:4206. doi: 10.3390/molecules28104206,

PubMed Abstract | Crossref Full Text | Google Scholar

204. Arzani, V, Soleimani, M, Fritsch, T, Jacob, UM, Calabrese, V, and Arzani, A. Plant polyphenols, terpenes, and terpenoids in oral health. Open Med. (2025) 20:20251183. doi: 10.1515/med-2025-1183,

PubMed Abstract | Crossref Full Text | Google Scholar

205. Odo, EO, Ikwuegbu, JA, Obeagu, EI, Chibueze, SA, and Ochiaka, RE. Analysis of the antibacterial effects of turmeric on particular bacteria. Medicine (Baltimore). (2023) 102:e36492. doi: 10.1097/md.0000000000036492,

PubMed Abstract | Crossref Full Text | Google Scholar

206. Xu, J, Ren, C, Wang, S, Liu, D, Cao, L, and Tao, J. Protection efficacy of multivalent egg yolk immunoglobulin against Eimeria tenella infection in chickens. Iran J Parasitol. (2013) 8:449–58.

PubMed Abstract | Google Scholar

207. Mahdavi, A, Rahmani, H, Nili, N, Samie, A, and Soleimania, S. Chicken egg yolk antibody (IgY) powder against Escherichia coli O78: K80. J Anim Vet Adv. (2010) 9:366–73. doi: 10.3923/javaa.2010.366.373

Crossref Full Text | Google Scholar

208. Mahdavi, AH, Rahmani, HR, Nili, N, Samie, AH, Soleimanian-Zad, S, and Jahanian, R. Effects of dietary egg yolk antibody powder on growth performance, intestinal Escherichia coli colonization, and immunocompetence of challenged broiler chicks. Poult Sci. (2010) 89:484–94. doi: 10.3382/ps.2009-00541,

PubMed Abstract | Crossref Full Text | Google Scholar

209. Al Adwani, S, Crespo, R, and Shah, D. Production and evaluation of chicken egg-yolk-derived antibodies against Campylobacter jejuni colonization-associated proteins. Foodborne Pathog Dis. (2013) 10:624–31. doi: 10.1089/fpd.2012.1313

Crossref Full Text | Google Scholar

210. Hermans, D, Van Steendam, K, Verbrugghe, E, Verlinden, M, Martel, A, Seliwiorstow, T, et al. Passive immunization to reduce Campylobacter jejuni colonization and transmission in broiler chickens. Vet Res. (2014) 45:27. doi: 10.1186/1297-9716-45-27,

PubMed Abstract | Crossref Full Text | Google Scholar

211. Abd El-Ghany, W. Comparison between immunoglobulins IgY and the vaccine for prevention of infectious bursal disease in chickens. Glob Veterinaria. (2011) 6:16–24.

Google Scholar

212. Vandeputte, J, Martel, A, Canessa, S, Van Rysselberghe, N, De Zutter, L, Heyndrickx, M, et al. Reducing Campylobacter jejuni colonization in broiler chickens by in-feed supplementation with hyperimmune egg yolk antibodies. Sci Rep. (2019) 9:8931. doi: 10.1038/s41598-019-45380-z,

PubMed Abstract | Crossref Full Text | Google Scholar

213. Farooq, A, Rabbani, M, Khushi, M, Akram, Z, Ahad, A, Fatima, Z, et al. Passive immunization in infectious bursal disease virus infected birds using chemically purified immune yolk immunoglobulins (IgY). Afr J Microbiol Res. (2012) 6:49. doi: 10.5897/AJMR12.049

Crossref Full Text | Google Scholar

214. Kweon, CH, Kwon, BJ, Woo, SR, Kim, JM, Woo, GH, Son, DH, et al. Immunoprophylactic effect of chicken egg yolk immunoglobulin (Ig Y) against porcine epidemic diarrhea virus (PEDV) in piglets. J Vet Med Sci. (2000) 62:961–4. doi: 10.1292/jvms.62.961,

PubMed Abstract | Crossref Full Text | Google Scholar

215. Vega, CG, Bok, M, Vlasova, AN, Chattha, KS, Fernández, FM, Wigdorovitz, A, et al. IgY antibodies protect against human rotavirus induced diarrhea in the neonatal gnotobiotic piglet disease model. PLoS One. (2012) 7:e42788. doi: 10.1371/journal.pone.0042788,

PubMed Abstract | Crossref Full Text | Google Scholar

216. Vega, C, Bok, M, Chacana, P, Saif, L, Fernandez, F, and Parreño, V. Egg yolk IgY: protection against rotavirus induced diarrhea and modulatory effect on the systemic and mucosal antibody responses in newborn calves. Vet Immunol Immunopathol. (2011) 142:156–69. doi: 10.1016/j.vetimm.2011.05.003,

PubMed Abstract | Crossref Full Text | Google Scholar

217. Zeng, X, Wang, H, Huang, C, Logue, CM, Barbieri, NL, Nolan, LK, et al. Evaluation of the immunogenic response of a novel Enterobactin conjugate vaccine in chickens for the production of Enterobactin-specific egg yolk antibodies. Front Immunol. (2021) 12:629480. doi: 10.3389/fimmu.2021.629480,

PubMed Abstract | Crossref Full Text | Google Scholar

218. Mesbahi Moghaddam, M, Rasooli, I, Ghaini, MH, Jahangiri, A, Ramezanalizadeh, F, and Ghasemkhah Tootkleh, R. Immunoprotective characterization of egg yolk immunoglobulin raised to loop 3 of outer membrane protein 34 (Omp34) in a murine model against Acinetobacter baumannii. Mol Immunol. (2022) 149:87–93. doi: 10.1016/j.molimm.2022.06.010,

PubMed Abstract | Crossref Full Text | Google Scholar

219. Ferreira, JÁ, Santiago, FM, Silva, MV, Ferreira, FB, Macêdo Júnior, AG, Mota, CM, et al. Production, characterization and applications for toxoplasma gondii-specific polyclonal chicken egg yolk immunoglobulins. PLoS One. (2012) 7:e40391. doi: 10.1371/journal.pone.0040391

Crossref Full Text | Google Scholar

220. Juárez-Estrada, MA, Tellez-Isaias, G, Sánchez-Godoy, FD, and Alonso-Morales, RA. Immunotherapy with egg yolk Eimeria sp.-specific immunoglobulins in spf leghorn chicks elicits successful protection against Eimeria tenella infection. Front Vet Sci. (2021) 8:758379. doi: 10.3389/fvets.2021.758379,

PubMed Abstract | Crossref Full Text | Google Scholar

221. Chiurciu, C, Chiurciu, V, Oporanu, M, Pătrașcu, IV, Mihai, I, Tablică, M, et al. PC2 ovotransferrin: characterization and alternative immunotherapeutic activity. Evid Based Complement Alternat Med. (2017) 2017:8671271. doi: 10.1155/2017/8671271,

PubMed Abstract | Crossref Full Text | Google Scholar

222. Ding, J, Liu, QR, Han, JP, Qian, WF, and Liu, Q. Anti-recombinant gametocyte 56 protein IgY protected chickens from homologous coccidian infection. J Integr Agric. (2012) 11:1721–8. doi: 10.1016/s2095-3119(12)60176-2,

PubMed Abstract | Crossref Full Text | Google Scholar

223. Sampaio, LCL, Baldissera, MD, Sagrillo, M, Heres, T, Oliveira, CB, Stainki, DR, et al. In vitro cytotoxicity and genotoxicity of chicken egg yolk antibodies (IGY) against Trypanosoma evansi in human lymphocytes. Int J Pharm Pharm Sci. (2006) 6:167–70.

Google Scholar

224. Burkard, C, Lillico, SG, Reid, E, Jackson, B, Mileham, AJ, Ait, AT, et al. Precision engineering for PRRSV resistance in pigs: macrophages from genome edited pigs lacking CD163 SRCR5 domain are fully resistant to both PRRSV genotypes while maintaining biological function. PLoS Pathog. (2017) 13:e1006206. doi: 10.1371/journal.ppat.1006206

Crossref Full Text | Google Scholar

225. Luo, C, Qu, H, Ma, J, Wang, J, Hu, X, Li, N, et al. A genome-wide association study identifies major loci affecting the immune response against infectious bronchitis virus in chicken. Infect Genet Evol. (2014) 21:351–8. doi: 10.1016/j.meegid.2013.12.004,

PubMed Abstract | Crossref Full Text | Google Scholar

226. Omersel, J, and Karas Kuželički, N. Vaccinomics and adversomics in the era of precision medicine: a review based on HBV, MMR, HPV, and COVID-19 vaccines. J Clin Med. (2020) 9:3561. doi: 10.3390/jcm9113561,

PubMed Abstract | Crossref Full Text | Google Scholar

227. Zheng, W, Wu, P, Zhu, M, Ullah, Y, Zhao, Z, Cao, S, et al. Establishment and validation of a method for the identification of recessive mastitis resistance genes in dairy cows. Genes. (2025) 16:485. doi: 10.3390/genes16050485,

PubMed Abstract | Crossref Full Text | Google Scholar

228. Gudra, D, Valdovska, A, Jonkus, D, Galina, D, Kairisa, D, Ustinova, M, et al. Genomic characterization and initial insight into mastitis-associated SNP profiles of local Latvian Bos taurus breeds. Animals (Basel). (2023) 13:2776. doi: 10.3390/ani13172776,

PubMed Abstract | Crossref Full Text | Google Scholar

229. Vlaicu, PA, Gras, MA, Untea, AE, Lefter, NA, and Rotar, MC. Advancing livestock technology: intelligent systemization for enhanced productivity, welfare, and sustainability. AgriEngineering. (2024) 6:1479–96. doi: 10.3390/agriengineering6020084

Crossref Full Text | Google Scholar

230. Hernández, VS, Bonilla, JA, García, AS, Arevalo, MS, Castrillo, D, Medina, VA, et al. Improving health and productivity in laying hens with the phage cocktail SalmoFree®. Poult Sci. (2025) 104:105638. doi: 10.1016/j.psj.2025.105638

Crossref Full Text | Google Scholar

231. Lim, TH, Kim, MS, Lee, DH, Lee, YN, Park, JK, Youn, HN, et al. Use of bacteriophage for biological control of Salmonella enteritidis infection in chicken. Res Vet Sci. (2012) 93:1173–8. doi: 10.1016/j.rvsc.2012.06.004,

PubMed Abstract | Crossref Full Text | Google Scholar

232. Ahmadi, M, Karimi Torshizi, MA, Rahimi, S, and Dennehy, JJ. Prophylactic bacteriophage administration more effective than post-infection administration in reducing Salmonella enterica serovar enteritidis shedding in quail. Front Microbiol. (2016) 7:1253. doi: 10.3389/fmicb.2016.01253,

PubMed Abstract | Crossref Full Text | Google Scholar

233. Oliveira, A, Sereno, R, Nicolau, A, and Azeredo, J. The influence of the mode of administration in the dissemination of three coliphages in chickens. Poult Sci. (2009) 88:728–33. doi: 10.3382/ps.2008-00378,

PubMed Abstract | Crossref Full Text | Google Scholar

234. Benala, M, Vaiyapuri, M, Raveendran, K, George, JC, Sivam, V, and Badireddy, MR. Coliphage cocktails for controlling antimicrobial-resistant Escherichia coli: emphasizing polyphage and multihost interactions at different levels of multiplicity of infection. J Appl Microbiol. (2023) 134:lxad055. doi: 10.1093/jambio/lxad055,

PubMed Abstract | Crossref Full Text | Google Scholar

235. Carvalho, CM, Gannon, BW, Halfhide, DE, Santos, SB, Hayes, CM, Roe, JM, et al. The in vivo efficacy of two administration routes of a phage cocktail to reduce numbers of Campylobacter coli and Campylobacter jejuni in chickens. BMC Microbiol. (2010) 10:232. doi: 10.1186/1471-2180-10-232,

PubMed Abstract | Crossref Full Text | Google Scholar

236. Mohammadian, F, Rahmani, HK, Bidarian, B, and Khoramian, B. Isolation and evaluation of the efficacy of bacteriophages against multidrug-resistant (MDR), methicillin-resistant (MRSA) and biofilm-producing strains of Staphylococcus aureus recovered from bovine mastitis. BMC Vet Res. (2022) 18:406. doi: 10.1186/s12917-022-03501-3,

PubMed Abstract | Crossref Full Text | Google Scholar

237. Volozhantsev, NV, Borzilov, AI, Shpirt, AM, Krasilnikova, VM, Verevkin, VV, Denisenko, EA, et al. Comparison of the therapeutic potential of bacteriophage KpV74 and phage-derived depolymerase (β-glucosidase) against Klebsiella pneumoniae capsular type K2. Virus Res. (2022) 322:198951. doi: 10.1016/j.virusres.2022.198951,

PubMed Abstract | Crossref Full Text | Google Scholar

238. Hawkins, C, Harper, D, Burch, D, Anggård, E, and Soothill, J. Topical treatment of Pseudomonas aeruginosa otitis of dogs with a bacteriophage mixture: a before/after clinical trial. Vet Microbiol. (2010) 146:309–13. doi: 10.1016/j.vetmic.2010.05.014,

PubMed Abstract | Crossref Full Text | Google Scholar

239. Moodley, A, Kot, W, Nälgård, S, Jakociune, D, Neve, H, Hansen, LH, et al. Isolation and characterization of bacteriophages active against methicillin-resistant Staphylococcus pseudintermedius. Res Vet Sci. (2019) 122:81–5. doi: 10.1016/j.rvsc.2018.11.008,

PubMed Abstract | Crossref Full Text | Google Scholar

240. Albino, LA, Rostagno, MH, Húngaro, HM, and Mendonça, RC. Isolation, characterization, and application of bacteriophages for Salmonella spp. biocontrol in pigs. Foodborne Pathog Dis. (2014) 11:602–9. doi: 10.1089/fpd.2013.1600,

PubMed Abstract | Crossref Full Text | Google Scholar

241. Cha, SB, Yoo, AN, Lee, WJ, Shin, MK, Jung, MH, Shin, SW, et al. Effect of bacteriophage in enterotoxigenic Escherichia coli (ETEC) infected pigs. J Vet Med Sci. (2012) 74:1037–9. doi: 10.1292/jvms.11-0556

Crossref Full Text | Google Scholar

242. Waseh, S, Hanifi-Moghaddam, P, Coleman, R, Masotti, M, Ryan, S, Foss, M, et al. Orally administered P22 phage tailspike protein reduces Salmonella colonization in chickens: prospects of a novel therapy against bacterial infections. PLoS One. (2010) 5:e13904. doi: 10.1371/journal.pone.0013904,

PubMed Abstract | Crossref Full Text | Google Scholar

243. Morello, E, Saussereau, E, Maura, D, Huerre, M, Touqui, L, and Debarbieux, L. Pulmonary bacteriophage therapy on Pseudomonas aeruginosa cystic fibrosis strains: first steps towards treatment and prevention. PLoS One. (2011) 6:e16963. doi: 10.1371/journal.pone.0016963,

PubMed Abstract | Crossref Full Text | Google Scholar

244. Alemayehu, D, Casey, PG, McAuliffe, O, Guinane, CM, Martin, JG, Shanahan, F, et al. Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells. mBio. (2012) 3:e00029-00012. doi: 10.1128/mBio.00029-12

Crossref Full Text | Google Scholar

245. Wall, SK, Zhang, J, Rostagno, MH, and Ebner, PD. Phage therapy to reduce preprocessing Salmonella infections in market-weight swine. Appl Environ Microbiol. (2010) 76:48–53. doi: 10.1128/AEM.00785-09,

PubMed Abstract | Crossref Full Text | Google Scholar

246. Seo, BJ, Song, ET, Lee, K, Kim, JW, Jeong, CG, Moon, SH, et al. Evaluation of the broad-spectrum lytic capability of bacteriophage cocktails against various Salmonella serovars and their effects on weaned pigs infected with Salmonella typhimurium. J Vet Med Sci. (2018) 80:851–60. doi: 10.1292/jvms.17-0501,

PubMed Abstract | Crossref Full Text | Google Scholar

247. Li, Y, Lv, P, Shi, D, Zhao, H, Yuan, X, Jin, X, et al. A cocktail of three virulent phages controls multidrug-resistant Salmonella enteritidis infection in poultry. Front Microbiol. (2022) 13:940525. doi: 10.3389/fmicb.2022.940525,

PubMed Abstract | Crossref Full Text | Google Scholar

248. Bhargava, K, Gururaj, K, Aseri, GK, Nath, G, Singh, NP, Pawaiya, RVS, et al. Bacteriophages: a possible solution to combat enteropathogenic Escherichia coli infections in neonatal goats. Lett Appl Microbiol. (2022) 74:707–17. doi: 10.1111/lam.13656,

PubMed Abstract | Crossref Full Text | Google Scholar

249. Ngassam-Tchamba, C, Duprez, JN, Fergestad, M, De Visscher, A, L'Abee-Lund, T, De Vliegher, S, et al. In vitro and in vivo assessment of phage therapy against Staphylococcus aureus causing bovine mastitis. J Glob Antimicrob Resist. (2020) 22:762–70. doi: 10.1016/j.jgar.2020.06.020

Crossref Full Text | Google Scholar

250. Fujiki, J, Furusawa, T, Munby, M, Kawaguchi, C, Matsuda, Y, Shiokura, Y, et al. Susceptibility of Pseudomonas aeruginosa veterinary isolates to Pbunavirus PB1-like phages. Microbiol Immunol. (2020) 64:778–82. doi: 10.1111/1348-0421.12846,

PubMed Abstract | Crossref Full Text | Google Scholar

251. Furusawa, T, Iwano, H, Hiyashimizu, Y, Matsubara, K, Higuchi, H, Nagahata, H, et al. Phage therapy is effective in a mouse model of bacterial equine keratitis. Appl Environ Microbiol. (2016) 82:5332–9. doi: 10.1128/aem.01166-16,

PubMed Abstract | Crossref Full Text | Google Scholar

252. Titze, I, Lehnherr, T, Lehnherr, H, and Krömker, V. Efficacy of bacteriophages against Staphylococcus aureus isolates from bovine mastitis. Pharmaceuticals (Basel). (2020) 13:35. doi: 10.3390/ph13030035,

PubMed Abstract | Crossref Full Text | Google Scholar

253. Vander Elst, N, Linden, SB, Lavigne, R, Meyer, E, Briers, Y, and Nelson, DC. Characterization of the bacteriophage-derived endolysins PlySs2 and PlySs9 with in vitro lytic activity against bovine mastitis Streptococcus uberis. Antibiotics (Basel). (2020) 9:621. doi: 10.3390/antibiotics9090621,

PubMed Abstract | Crossref Full Text | Google Scholar

254. Hamza, A, Perveen, S, Abbas, Z, and Rehman, SU. The lytic SA phage demonstrate bactericidal activity against mastitis causing Staphylococcus aureus. Open Life Sci. (2016) 11:39–45. doi: 10.1515/biol-2016-0005

Crossref Full Text | Google Scholar

255. Fan, J, Zeng, Z, Mai, K, Yang, Y, Feng, J, Bai, Y, et al. Preliminary treatment of bovine mastitis caused by Staphylococcus aureus, with trx-SA1, recombinant endolysin of S. aureus bacteriophage IME-SA1. Vet Microbiol. (2016) 191:65–71. doi: 10.1016/j.vetmic.2016.06.001,

PubMed Abstract | Crossref Full Text | Google Scholar

256. Ganaie, MY, Qureshi, S, Kashoo, Z, Wani, SA, Hussain, MI, Kumar, R, et al. Isolation and characterization of two lytic bacteriophages against Staphylococcus aureus from India: newer therapeutic agents against bovine mastitis. Vet Res Commun. (2018) 42:289–95. doi: 10.1007/s11259-018-9736-y,

PubMed Abstract | Crossref Full Text | Google Scholar

257. Kaspar, U, Sautto, JAd H, Molinaro, S, Peters, G, Idelevich, EA, and Becker, K. The novel phage-derived antimicrobial agent HY-133 is active against livestock-associated methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. (2018) 62:318. doi: 10.1128/AAC.00385-18

Crossref Full Text | Google Scholar

258. van Gastelen, S, Burgers, EE, Dijkstra, J, de Mol, R, Muizelaar, W, Walker, N, et al. (2024). Long-term effects of 3-nitrooxypropanol on methane emission and milk production characteristics in Holstein-Friesian dairy cows. Journal of dairy Science, 107:5556–5573. doi: 10.3168/jds.2023-24198,

PubMed Abstract | Crossref Full Text | Google Scholar

259. World Health Organization. (2012). The evolving threat of antimicrobial resistance: options for action. Available online at: http://whqlibdoc.who.int/publications/2012/9789241503181_eng.pdf (Accessed November 12, 2015).

Google Scholar

Keywords: antibiotic alternatives, phytogenic feed additives, antimicrobial peptides, IgY antibody applications, bacteriophage therapy, symbiotic

Citation: Abbas M, Abbas G, Fatima, Hashmi AH, Jaffery S, Li Y, Zhao G and Xihe L (2026) Sustainable AGP alternatives: a systems approach to non-antibiotic growth regulators standardization, synergistic formulation and environmental safety. Front. Vet. Sci. 12:1695160. doi: 10.3389/fvets.2025.1695160

Received: 29 August 2025; Revised: 07 October 2025; Accepted: 13 November 2025;
Published: 30 January 2026.

Edited by:

Matteo Dell'Anno, University of Messina, Italy

Reviewed by:

Kyle R. Leistikow, Microbial Discovery Group, United States
Jalmeen Kour, Chaudhary Sarwan Kumar Himachal Pradesh Krishi Vishvavidyalaya, India

Copyright © 2026 Abbas, Abbas, Fatima, Hashmi, Jaffery, Li, Zhao and Xihe. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Li Xihe, bGl4aEBpbXUuZWR1LmNu

These authors have contributed equally to this work and share first authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.